SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN THE TREATMENT OF ASCENDING AORTIC DISEASE, TRANSCATHETER VALVE REPLACEMENT AND CORONARY ARTERY STENTING
x
6:45 AM - 6:50 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
CORONARY STENTS
6:50 AM - 6:55 AM What Is New In Coronary Stenting: Current Status Of Non-Absorbable Stents, Drug Eluting And Bare Metal
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
6:56 AM - 7:01 AM Update Of Bioabsorbable Stents (BRSs) In The Coronary Arteries: Why Did The Absorb Stent Fail: Is There Hope For BRSs In The Future – In Coronary Or Peripheral Arteries
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
THE ASCENDING AORTA
7:02 AM - 7:07 AM Current Status Of Endovascular Treatment For Ascending Aortic Lesions: What Patients, What Pathology, What Devices Exist
  Presenter(s):Grayson H. Wheatley, MD  
  View Slides in PDF      
7:08 AM - 7:14 AM Update On Ascending Aortic Endograft Treatment: Indications, Devices, Techniques And Results
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
7:15 AM - 7:21 AM Status Of Endovascular Combined Device For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
7:22 AM - 7:28 AM Will New Ascending Aortic Endografts Enable Treatment Of Type A Aortic Dissections: What Percentage Of Patients: What Is Here And What Is The Future
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
TRANSCATHETER HEART VALVES
7:29 AM - 7:29 AM Progress In Transcatheter Aortic Valve Replacement (TAVR): An Interventional Cardiologist’s View. This presentation will be given by Martin B. Leon on Thursday, Session 47 at 7:03 to 7:98 a.m. in the Grand Ballroom East.
7:29 AM - 7:35 AM Progress In TAVR: A Cardiac Surgeon’s View: What Is The Current Place For Open Surgical Aortic Valve Replacement
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
7:36 AM - 7:42 AM Progress In Endovascular Mitral Valve Repair: What Devices Are Appearing And How Well Are They Working
  Presenter(s):Juan F. Granada, MD  
  View Slides in PDF      
7:43 AM - 7:51 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
x
7:51 AM - 7:56 AM With Aortic Arch Lesions (Aneurysms And Dissections), When Should The Treatment Be Fenestrated Or Branched TEVAR (F/B/TEVAR), Chimney TEVAR (Ch/TEVAR), Hybrid Or Fully Open Surgical Repair
  Presenter(s):Chang Shu, MD  
  View Slides in PDF      
7:57 AM - 8:02 AM Another View Of Current Optimal Treatment Of Aortic Arch Aneurysms: Total Endovascular, Hybrid, Open And Frozen Elephant Trunk: Which Is Best When
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
  View Slides in PDF      
8:03 AM - 8:08 AM Update On Value And Limitations Of Frozen Elephant Trunk Repairs And The ThoroFlex Graft For Complex Aortic Arch Lesions: Is Spinal Cord Ischemia An Issue
  Presenter(s):Joseph S. Coselli, MD  
  View Slides in PDF      
8:09 AM - 8:14 AM Six-Year Results With Terumo Aortic Relay 2 Branched Device For Aortic Arch Lesions: Indications And Contraindications
  Presenter(s):Toru Kuratani, MD, PhD  
  View Slides in PDF      
8:15 AM - 8:20 AM Update On Total Endovascular Arch Repairs Using Cook Multibranched Devices: When Indicated, When Questionable, When Not Indicated; Advantages And Limitations
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
8:21 AM - 8:26 AM Total Endovascular Aortic Arch Repairs With The Relay 2-Branched Endograft: The US Experience – Advantages And Limitations
  Presenter(s):Eric E. Roselli, MD  
  View Slides in PDF      
8:27 AM - 8:32 AM Physician-Made Fenestrated Endograft Repair For Aortic Arch Lesions: Experience In >115 Cases: Challenges And Technical Tips
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
8:33 AM - 8:38 AM Experience With Branched Endografts For Treatment Of Aortic Arch Lesions
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
8:39 AM - 8:44 AM Long-Term Results (>4 Years) Of Parallel Grafts (Chimneys And Periscopes) For Aortic Arch Lesions; Tips To Make Them Work And When Do They
  Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD  
  View Slides in PDF      
8:45 AM - 8:50 AM Results And Advantages With A Precurved Convertible F/B Endograft For Arch Lesions: How It Compares With Other Arch Grafts And Will It Be Available Outside Japan
  Presenter(s):Yoshihiko Yokoi, MD  
  View Slides in PDF      
8:51 AM - 8:56 AM Real World Experience With Double Branched Endografts For Aortic Arch Lesions: Are They Ready For Prime Time: From The Italian And Dutch Registries
  Presenter(s):Piergiorgio Cao, MD, FRCS / Ciro Ferrer, MD  
  View Slides in PDF      
8:57 AM - 9:04 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: PETTICOAT, STABILISE, FLIRT, FENESTRATIONS AND TEVAR’S EFFECTS ON THE HEART
x
9:04 AM - 9:09 AM Evolving An Optimal Treatment For Type B Aortic Dissections (TBADs) With TEVAR And False Lumen Embolization: TechniqueS And Results
  Presenter(s):Weiguo Fu, MD  
  View Slides in PDF      
9:10 AM - 9:15 AM Fenestration And Branched EVAR (F/B/VAR) To Treat Post TBAD AAAs: Technical Tips, Results And Limitations
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
9:16 AM - 9:21 AM Update On PETTICOAT TEVAR For TBADs: Why The Addition Of A Distal Bare Dissection Stent To A Proximal Covered Stent Facilitates Treatment And Improves Outcomes
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
9:22 AM - 9:27 AM Impact Of The PETTICOAT Technique (With A Distal Bare Stent Added To A Proximal Covered Stent) On Aortic Remodeling With Chronic TBADs: Indications, Timing Of Treatment And Results
  Presenter(s):Chun Che Shih, MD, PhD  
  View Slides in PDF      
9:28 AM - 9:33 AM The STABILISE Modification Of The PETTICOAT Technique To Rupture The Dissection Flap And Promote False Lumen Obliteration To Treat TBADs: Concept, Indications And Results
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
9:34 AM - 9:39 AM Another Opinion About The STABILISE Modification Of The PETTICOAT Technique To Disrupt The Dissection Flap With A Compliant Balloon In The Covered Stent And A Non-Compliant Balloon In The Bare Stent: Precautions And Results
  Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM Long Stent Grafts For TEVAR Have Bad Effects On The Heart And Tend To Migrate Proximally Causing Type 1B Endoleaks: What Are The Mechanisms
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
9:46 AM - 9:51 AM Update On Extensive Flap Disruption (Fenestration) To Treat TBADs: Why It Works By Equalizing Pressure In The 2 Lumens, Indications And Results
  Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM Open Surgical Flap Excision In The Abdominal Aorta To Treat Complex Dissections: Indications, Theory, Technique, Precautions And Results
  Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC  
  View Slides in PDF      
9:57 AM - 10:11 AM Panel Discussion
10:11 AM - 10:21 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
x
10:21 AM - 10:26 AM Evidence For And Risks Of Endovascular Treatment Of Asymptomatic Acute Type B Aortic Dissection: Is TEVAR Really A Good Treatment
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
  View Slides in PDF      
10:27 AM - 10:32 AM Long-Term Successful Treatment Of TBADs With Total Aortic Remodeling Usually Requires Multiple Re-Interventions – Many Long After The Original TEVAR: What Are These Re-Interventions
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
10:33 AM - 10:38 AM A New Classification System For Aortic Dissections: Better For Prognosis, Predicting Complications And Guiding Treatment
  Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD  
  View Slides in PDF      
10:39 AM - 10:44 AM F/B/EVAR Treatment Of Chronic TBADs With An Enlarging AAA After TEVAR: A Positive 8-Year Experience; How To Deal With A Small True Lumen And Value Of Inner Branches
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
10:45 AM - 10:50 AM How To Manage Re-Entry Sites In The Arch And Visceral Segment Of The Aorta After TEVAR For TBADs
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
10:51 AM - 10:56 AM Update On False Lumen Occlusion Techniques And Value After TEVAR For TBADs: New Devices; When Indicated; Results And When Preferred Over F/B/EVAR In Patients With AAAs
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
10:57 AM - 11:02 AM Effectiveness Of False Lumen Embolization For Chronic TBADs With Progressive Aortic Enlargement: Devices, Techniques And Results
  Presenter(s):Herve Rousseau, MD, PhD  
  View Slides in PDF      
11:03 AM - 11:08 AM A New Modular Branched Stent-Graft For Aortic Arch Reconstruction: Advantages And Limitations From A First In Man Study
  Presenter(s):Wei Guo, MD  
  View Slides in PDF      
11:09 AM - 11:15 AM Panel Discussion
11:15 AM - 11:20 AM Improvements In Techniques And Grafts For Open TAAA Repair: In Virginal Cases And After Failed Endovascular Procedures
  Presenter(s):Hazim J. Safi, MD  
  View Slides in PDF      
11:21 AM - 11:26 AM Open TAAA Repair After Failed TEVAR Or Endovascular TAAA Repair: Technical Advances And Results: Who Should Do These Redo Procedures
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
  View Slides in PDF      
11:27 AM - 11:32 AM Importance Of A Type III Aortic Arch And Descending Aorta Tortuosity In Determining Outcomes Of TEVAR And Treating TBADs: How To Deal With These Issues
  Presenter(s):Santi Trimarchi, MD, PhD  
  View Slides in PDF      
11:33 AM - 11:38 AM Current Status Of Cerebral Protection For TEVAR And TAVR: What Are The Devices, When Can They Help And When Not
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
11:39 AM - 11:44 AM Staged Endovascular And Open TAAA Repairs Reduces Morbidity And Mortality: When And How To Do It And Results
  Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD  
  View Slides in PDF      
11:45 AM - 11:50 AM TEVAR Has Better Long-Term Survival (>5 Years) Than Open Repair For Intact Descending Thoracic Aortic Aneurysms: TEVAR Should Be The Standard Of Care; Randomized Trials (RCTs) Are Not Needed
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
11:51 AM - 11:56 AM Short And Long-Term Comparison In Canada Of Open And Endo TAAA Repair Regarding Outcomes And Cost: Endo Is Best
  Presenter(s):Thomas F. Lindsay, MDCM, FRCS, FACS  
  View Slides in PDF      
11:57 AM - 12:03 PM Panel Discussion
12:03 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
x
1:00 PM - 1:05 PM How And Why Is AAA Disease Different In Diabetics: How Do These Differences Impact Treatment
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Update On The Nellix Graft And EVAS: Will Nellix Be A Failure Or A Phoenix Surmounting Its Problems
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Why Are AAA Patients Surviving More: What Is Its Impact On Screening And Size Criteria For Repair
  Presenter(s):Anders Wanhainen, MD, PhD / Jes S. Lindholt, MD  
1:18 PM - 1:23 PM Value Of Metformin And Ticagrelor In Inhibiting The Growth Of Small AAAs: What Is The Long-Term Fate Of 25-29 mm Abdominal Aortas: How Many Will Become AAAs
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
SHORT SUMMARY TOPICS (3-4 MINUTES)
1:24 PM - 1:28 PM Influence Of Metformin On AAA Derived Cells In Culture: A Clue To How Metformin Slows AAA Growth
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
1:28 PM - 1:32 PM Update On The Value Of And Indications For Pre EVAR Lumbar And Inferior Mesenteric Artery Embolization
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
1:32 PM - 1:36 PM DEBATE: There Are Several Good Reasons To Electively Repair AAAs <5.5 cm In Maximum Diameter: What Are They
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
1:36 PM - 1:40 PM DEBATE: Why AAAs < 5.5 cm Should Not Be Treated Invasively: The Rupture Rate (< 1%/Year) Is Less Than Commonly Thought
  Presenter(s):Jonothan J. Earnshaw, FRCS  
  View Slides in PDF      
1:40 PM - 1:45 PM Panel Discussion
Moderator(s): Mark A. Adelman, MD / Michel Makaroun, MD  
1:45 PM - 1:50 PM DEBATE: Young Fit AAA Patients Have Better Long-Term Survival With Open Repair (OR) Than EVAR And Should Be Offered OR If They Need Invasive Treatment
  Presenter(s):Andrew W. Bradbury, MD, FRCSEd  
  View Slides in PDF      
1:51 PM - 1:56 PM DEBATE: Not So: Survival Is Better In Young Fit AAA Patients After EVAR Than OR
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
1:57 PM - 2:02 PM Why Open Repair Of AAAs Has Improving Outcomes: When Is OR Indicated And Better For Patients
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
2:03 PM - 2:08 PM In AAA Patients Suitable For Both OR And EVAR Unfavorable Neck Characteristics (Short, Wide, Angulated Or Cone Shaped) Have More Adverse Outcomes And Higher Mortality After OR As Well As EVAR: From The DREAM RCT: How Should This Impact On AAA Treatment Decisions
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
2:09 PM - 2:14 PM Migration Patterns In Newer Lower Profile EVAR Stent-Grafts: What Are The Implications For EVAR Planning And Follow-Up
  Presenter(s):Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
2:15 PM - 2:20 PM Optimal Current Treatment For Inflammatory AAAs: When Medical; When Endo; When Open
  Presenter(s):Franco Grego, MD  
  View Slides in PDF      
2:21 PM - 2:26 PM EVAS Treated Patients (With Nellix) Have A Lower 3-Year Mortality Than EVAR Treated Patients: What Is The Mechanism And Is This Difference Restricted To Patients With AAAs >5.5 cm
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
2:27 PM - 2:32 PM Another View Of Why EVAS Treated Patients (With Nellix) Have A Lower Mortality Than EVAR Treated Patients: What Is The Mechanism And Is This Difference Restricted To Patients With AAAs >5.5 cm
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
2:33 PM - 2:38 PM Panel Discussion
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: MORE ABOUT AAAs AND EVAR; THE NICE GUIDELINES AND REACTIONS TO THEM
x
2:38 PM - 2:43 PM Highlights Of Clinical Practice Guidelines For Endovascular Repair Of Complex AAAs Involving The Paravisceral Aorta
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
2:44 PM - 2:49 PM Sac Shrinkage Is A Good Marker Of Durable Success After EVAR: Is There A Difference In This Marker With Different Endografts
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
2:50 PM - 2:55 PM Long-Term Results Of EVAR Outside Device IFUs Is Not So Bad: When Is It Acceptable To Use EVAR Devices Outside Their IFUs
  Presenter(s):Bibombe Patrice Mwipatayi, MMed, MClinEd, FCS, FRACS  
  View Slides in PDF      
2:56 PM - 3:01 PM When Is EVAR First The Best Option For Repairing AAAs And When Is Open Repair First The Best Option: Late Failures Raise Questions Especially With Large Diameter Necks And Outside The IFUs
  Presenter(s):Daniel G. Clair, MD  
  View Slides in PDF      
THE UK NICE AAA GUIDELINES AND REACTIONS TO THEM
3:02 PM - 3:07 PM Highlights Of The UK NICE Guidelines For Treating Elective And Ruptured AAAs: Why Do They Favor Open Repair Over EVAR And What Was The Influence Of The EVAR 1 Late Results
  Presenter(s):Andrew W. Bradbury, MD, FRCSEd  
  View Slides in PDF      
3:08 PM - 3:13 PM Why The Early Survival Benefit For EVAR Versus Open Repair Outweighs The Late Survival Benefit For Open Repair Versus EVAR
  Presenter(s):Nicholas J.W. Cheshire, MD  
  View Slides in PDF      
MORE COMMENTS ON THE NICE AAA GUIDELINES
3:14 PM - 3:18 PM The NICE AAA Guidelines Are Misleading And Unfairly Biased Against EVAR
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
3:18 PM - 3:22 PM Why The NICE AAA Guidelines Reached The Wrong Conclusions – That EVAR Benefits Were Not Worth The Costs
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
3:22 PM - 3:26 PM What Is Right In The NICE AAA Guidelines And What Is Wrong In Them
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
3:26 PM - 3:30 PM Flaws In The NICE Guidelines For Treating AAAs: How They Were Based On Biases Of The Writing Committee And Why They Will Have An Impact Beyond The UK
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
3:30 PM - 3:36 PM Panel Discussion
3:36 PM - 3:46 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC AORTIC PATHOLOGY
x
3:46 PM - 3:51 PM Best Medical Therapy For Acute TBAD Patients: What Is It And Strategies To Optimize It: How Effective Can It Be
  Presenter(s):Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
3:52 PM - 3:57 PM New Concepts In The Pathogenesis Of TBADs: What Are The Therapeutic Implications: What Is Best Medical Therapy For TBAD: Principles And Paradoxes
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
3:58 PM - 4:03 PM Technical Tips To Improve Or Increase The Use And Safety Of The Cook T-Branch Off-The-Shelf (OTS) Device For TAAAs
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
4:04 PM - 4:09 PM Aortic Arch Anomalies, Especially Bovine Arches: What Are Their Bad Implications For Patients And Treatment Outcomes
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
4:10 PM - 4:15 PM Update On The Natural History Of Penetrating Aortic Ulcers (PAUs) And Intramural Hematomas (IMHs) With And Without TEVAR Treatment: Medical Treatment Has A High Failure Rate: So When And How Should They Be Treated
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:16 PM - 4:21 PM Making EVAR Safer Long-Term Using Ultrasound Made Simple To Measure AAA Sac Diameter At Home
  Presenter(s):Roger M. Greenhalgh, MD  
TIMING OF EVAR FOR UNCOMPLICATED TBAD
4:22 PM - 4:27 PM TEVAR Can Be Performed Safely Soon After Symptom Onset With TBADs Under Certain Conditions
  Presenter(s):Edward Y. Woo, MD / Tareq Massimi, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM With Uncomplicated TBADs TEVAR Should Be Performed As Soon As Possible After Onset Of Symptoms: For These Reasons And With These Precautions
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
4:34 PM - 4:39 PM Not So: With Uncomplicated Acute TBADs TEVAR Should Be Delayed 2 Weeks To 3 Months For These Reasons
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
4:40 PM - 4:45 PM With Uncomplicated Acute TBADs TEVAR Should Be Delayed For 1-3 Months After Symptom Onset And Why
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
4:46 PM - 4:53 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: MORE NEW DEVELOPMENTS RELATING TO TEVAR AND TBADs: CAUSES AND PREVENTION OF STROKE COMPLICATIONS; CONTROVERSIES OVER THE NEED FOR TEVAR IN SOME OR ALL ACUTE UNCOMPLICATED TBAD PATIENTS, AND OVER THE EXTENT OF TEVAR COVERAGE
x
4:53 PM - 4:58 PM Status Of Stroke Prevention During TEVAR: What Percent Are Due To Particulate Emboli And What Percent Due To Air Emboli: Techniques To Prevent Both
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
4:59 PM - 5:04 PM Causes Of Stroke During TEVAR: Gaseous Emboli Are Important And Some But Not All Can Be Prevented By CO2 Flushing Of Delivery Systems
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
5:05 PM - 5:10 PM The STEP Registry: A Global Network To Decrease Strokes Associated With Thoracic Aortic Endografting Procedures: How Will It Work
  Presenter(s):Fiona Rohlffs, MD / Stephan Haulon, MD / Tilo Koelbel, MD, PhD  
  View Slides in PDF      
5:11 PM - 5:16 PM IVUS Need Not Be Mandatory To Treat TBADs By TEVAR Safely: How So
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
5:17 PM - 5:22 PM DEBATE: Most Acute Uncomplicated TBADs Need To Be Treated By TEVAR: The INSTEAD RCT Proves It: We Do Not Need Further RCTs
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
5:23 PM - 5:28 PM DEBATE: Not So: Controversy Lingers: We Do Need A RCT Comparing TEVAR With Best Medical Treatment (BMT) To BMT Alone For Acute Uncomplicated TBADs: How Could Such A Trial Be Structured And Financed
  Presenter(s):Firas F. Mussa, MD  
  View Slides in PDF      
5:29 PM - 5:34 PM Why TEVAR For Acute Uncomplicated TBADs Is Imperfect: The Case For Using It Selectively
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
5:35 PM - 5:40 PM DEBATE: Treating More Acute Uncomplicated TBAD Patients With Extended TEVAR Coverage Almost To The Celiac Artery Will Improve Outcomes: It Is The Way To Go
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
5:41 PM - 5:46 PM DEBATE: Not So: Limited Coverage Of The Thoracic Aorta By TEVAR Is Safer And Better
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
5:47 PM - 5:52 PM A Decision-Making Algorithm For Optimally Treating Uncomplicated Acute TBAD Patients
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
5:53 PM - 6:00 PM Panel Discussion
End of Program A
END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, SIMULATION AND LAPAROSCOPY
x
VASCULAR ROBOTICS
6:45 AM - 6:50 AM A New Vascular Robotic System From Corindus: How Does It Work: What Does It Do: Clinical Experience And Value
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS  
  View Slides in PDF      
6:51 AM - 6:56 AM Current Status Of Endovascular Catheter Robotics: What Is Here And What Is Coming
  Presenter(s):Jean Bismuth, MD / Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
6:57 AM - 7:02 AM Will Newer Technology And Platforms Lead To More Widespread Use Of Vascular Robotics: What Is On The Horizon And Beyond
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM A New Vascular Robotic System From China: How Does It Work: Advantages: Cost And When Will It Be Available
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM Robotics In Vascular Surgery: What Is Available; What Is Coming And How Will It Help
  Presenter(s):Ravi K. Veeraswamy, MD  
  View Slides in PDF      
VASCULAR GUIDANCE
7:15 AM - 7:20 AM Machine Learning Based Measurement Of AAA Diameter With Contrast CT: A New And Better Way
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
7:21 AM - 7:26 AM Update On An Emerging Radiation Free 3D Endovascular Guiding System (IOPS) From Centerline (BIOM) Medical: How Does It Work; When Will We Have It; How Much Will It Cost
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
7:27 AM - 7:32 AM A New 3D Device Guidance Technology Within The Vascular Tree: Fiber Optic RealShape (FORS Technology): How Does It Work And Initial Results
  Presenter(s):Joost A. van Herwaarden, MD, PhD  
  View Slides in PDF      
7:33 AM - 7:38 AM Is There Real Evidence To Support The Value Of Simulation In Vascular Surgery: Vascular Surgery Endo And Open Is Not Like Piloting An Aircraft
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
LAPAROSCOPY
7:39 AM - 7:44 AM Laparoscopic Median Arcuate Ligament Release: The Best Way To Treat Celiac Artery Compression Syndrome: Advantages And Limitations And Who Should Do It
  Presenter(s):Joseph S. Giglia, MD / George H. Meier, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM Why I Stopped Doing Laparoscopic Aortic Surgery After Performing 160 Cases
  Presenter(s):Laurent Chiche, MD, FEBVS  
  View Slides in PDF      
7:51 AM - 7:59 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID DISEASE: UNRESOLVED CONTROVERSIES
x
7:59 AM - 8:04 AM Role And Value Of Biomarkers Of Brain Injury In CAS And CEA Procedures: How Can They Help Decision Making
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
8:05 AM - 8:10 AM Systemic Biomarkers Can Predict The Volume Of Cerebral Infarct Associated With Carotid Interventions: Is There A Difference Between CAS And CEA
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
8:11 AM - 8:16 AM Cerebral Hyperfusion Syndrome After CAS Procedures: Etiology, Diagnosis, Optimal Treatment And Prevention
  Presenter(s):Gert J. de Borst, MD, PhD  
  View Slides in PDF      
8:17 AM - 8:22 AM Intracranial Artery Dissection: An Unrecognized Cause Of Strokes: How To Diagnose And Treat It
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
8:23 AM - 8:28 AM Eversion CEA: Technical Tips, When Is It The Best Method For CEA And When Not
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
8:29 AM - 8:34 AM New Developments In Best Medical Treatment For Carotid Patients: Can Carotid Plaques Be Stabilized Or Shrunk: Will Strokes And MIs Become Rare Or Eliminated
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
8:35 AM - 8:40 AM DEBATE: CEA Must Include Completion Imaging With Duplex Or Angiography
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
8:41 AM - 8:46 AM DEBATE: Not So: Completion Duplex Can Be Misleading And Angiography Can Be Harmful And Misleading: Completion Imaging Causes More Harm Than Benefit
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
8:47 AM - 8:54 AM Panel Discussion
8:54 AM - 8:59 AM Avoiding And Managing Complications During Transfemoral CAS
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
9:00 AM - 9:05 AM Optimal Contemporary Treatment Of Carotid Artery Aneurysms, Pseudoaneurysms And Patch Infections: When Endo, When Open
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
9:06 AM - 9:11 AM How Best In 2019 To Pick Asymptomatic Patients With Unstable Plaques At High Risk Of Having A Stroke: Are There New Duplex Techniques Which Can Help
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
UPDATE ON CAROTID PATCHES
9:12 AM - 9:17 AM Careful Primary Closure Of CEA Arteriotomies (Without A Patch) Is Not Inferior To Patch Closures: In A Propensity Matched Analysis: Why Did The RCTs Get It Wrong
  Presenter(s):Dong-ik Kim, MD  
  View Slides in PDF      
9:18 AM - 9:23 AM All Patches For CEA Closure Are Not Equal: Which Patch Material Is Best: How Big Should The Patch Be: Disadvantages And Complications Of Carotid Patches
  Presenter(s):Vikram S. Kashyap, MD / Norman Kumins, MD  
  View Slides in PDF      
9:24 AM - 9:29 AM Should All CEA Closures Be Patched: Could The RCTs Indicating That All CEA Patients Should Have Patch Closures Be Misleading
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
9:30 AM - 9:35 AM Femoral Vein Interposition Grafts Are The Best Treatment For Patch Infections After CEA: Technical Tips
  Presenter(s):Salvatore T. Scali, MD / Thomas S. Huber, MD, PhD  
  View Slides in PDF      
9:36 AM - 9:41 AM Carotid Interventions CEA And CAS Will Become Obsolete: Why And When
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
9:42 AM - 9:48 AM Panel Discussion
9:48 AM - 9:58 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: MORE NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; PROGRESS IN THE INTERVENTIONAL MANAGEMENT OF ACUTE STROKES (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
x
9:58 AM - 10:03 AM Carotid Plaque Characteristics With Duplex, CT And MRI Can Predict High Stroke Risk Patients With Asymptomatic Carotid Stenosis
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
10:04 AM - 10:08 AM [SS] DEBATE: Long-Term Results Of Transfemoral CAS Are Equivalent To Those Of CEA – Maybe Even Better
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
10:08 AM - 10:12 AM [SS] DEBATE: Not So: Long-Term Results Of CAS Are Not Equal To Those Of CEA
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
10:12 AM - 10:16 AM [SS] Why Occlusion Of 1 Internal Carotid Artery (ICA) Is Not A Benign Condition Even If The Patient Is Asymptomatic
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
10:16 AM - 10:21 AM Value Of CAS In Treating Chronically Totally Occluded ICAs: Indications, Technical Tips, Results
  Presenter(s):Piotr Myrcha, MD, PhD  
  View Slides in PDF      
10:22 AM - 10:26 AM [SS] Limb Shaking TIAs: What Are They, What Imaging Should Be Performed And How Should They Be Treated
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
MANAGEMENT OF ACUTE STROKES
10:26 AM - 10:31 AM Merit Of MRI vs. CTA To Evaluate Acute Strokes And Their Treatment: MRI Is Better Than CTA
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
10:32 AM - 10:37 AM Urgent Interventional Treatment Of Strokes Complicating Cardiac Surgery, TEVAR And Other Endo Interventions: What Should Be Done Diagnostically And Therapeutically: Results
  Presenter(s):L. Nelson Hopkins, MD  
  View Slides in PDF      
10:38 AM - 10:43 AM For Acute Strokes Later Thrombus Removal From Intracranial Arteries Can Be Beneficial Even 6-16 Hours After Symptom Onset: What Are The Conditions For Success And In Which Patients
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
10:44 AM - 10:49 AM Mechanical Intracranial Thrombectomy For Acute Strokes Has Worse Results At Low Volume Centers: What Are The Implications And Which Physicians Should Be Performing These Procedures
  Presenter(s):L. Nelson Hopkins, MD / Colin P. Derdeyn, MD  
  View Slides in PDF      
10:50 AM - 10:55 AM Value Of Suction Thrombectomy Versus Stentrievers To Remove Intracranial Arterial Clot: Advantages Of Penumbra Devices (Jet 7 And Jet D) For Acute Stroke Treatment
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
10:56 AM - 11:00 AM [SS] What Is The Role Of The Vascular Surgeon In The Treatment Of Acute Strokes
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
11:00 AM - 11:06 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: PROGRESS IN THE TREATMENT OF AORTO-ILIAC AND ILIAC OCCLUSIVE DISEASE
x
11:06 AM - 11:11 AM Optimal Endovascular Treatment Of Aorto-Iliac Occlusive Disease: Proper Stent Or Stent-Graft Selection And Technical Tips
  Presenter(s):Jean Bismuth, MD  
  View Slides in PDF      
11:12 AM - 11:17 AM When Are Covered Stents The Best Treatment For Aorto-Iliac Occlusive Disease: Which Is The Best Stent-Graft For This: What Are The Long-Term Results
  Presenter(s):Bibombe Patrice Mwipatayi, MMed, MClinEd, FCS, FRACS  
  View Slides in PDF      
11:18 AM - 11:23 AM Update On The CERAB Procedure (Covered Endovascular Reconstruction of Aortic Bifurcation) For Aorto-Iliac Occlusive Disease: Technical Tips, 3-Year Results, What Is The Best Stent-Graft For This Procedure
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM Value Of The CERAB Procedure For Failed Iliac Stents: Technical Tips And Best Stent-Graft
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
11:30 AM - 11:35 AM Value Of Aortic (AAA) Endografts For Treatment Of Aorto-Iliac Occlusive Disease: Which Device Is Best And Results
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM What Is The Best Endovascular Device For Aorto-Iliac Occlusive Lesions: When Self-Expanding Stent; When Balloon Expandable Stent; Which Covered Stent And For Which Lesion
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM Thoraco-Bifemoral Bypass Is A Good Solution When Other Techniques Fail Or Are Contraindicated: Technical Tips And Results
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
11:48 AM - 11:53 AM When Limb Occlusion Occurs After An EVAR, Endovascular Solutions Are The Way To Go: Technical Tips To Make Them Safe And Effective
  Presenter(s):Klaus M. Overbeck, MD, MPhil  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: NEW OR UPDATED CONCEPTS AND TECHNIQUES; IMPORTANCE OF ARTIFICIAL INTELLIGENCE (AI) IN VASCULAR TREATMENT (5 AND ONE 4-MINUTE SHORT SUMMARY [SS] TALKS)
x
1:00 PM - 1:05 PM The Evidence Base For Clinical Decision Making In Lower Extremity Treatments Is Poor: Guidelines Are Often Based On Shaky Foundations: What Is Needed And Are Things Improving
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
1:06 PM - 1:11 PM Innovation In The Hybrid Operating Room And Angio Suite: What Future Developments Should We Expect: The Philips Azurion Flex C-Arm Fluoroscope Is One Example
  Presenter(s):Barry T. Katzen, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Advances In Transradial Access For Treating Non-Cardiac Arterial Lesions: Supplies Needed Like Sheathless Systems And 7 Key Technical Pillars To Make Radial Access Procedures Safe And Successful
  Presenter(s):Marcelo Guimaraes, MD, FSIR  
  View Slides in PDF      
1:18 PM - 1:23 PM Update After 2 Years Of The BATTLE RCT Showing Equivalence Of The Zilver PTX DES (Cook) And Misago Bare Stent (Terumo) For Fempop Lesions: Despite The Misago’s Suitability For Deployment Via Radial Access: How Is This Possible
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:28 PM [SS] What Is The Cutneedle And How Does It Facilitate Percutaneous Vascular Access
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
1:28 PM - 1:33 PM The Untethered Vascular Patient: How Sensor Technology And Telemedicine Will Improve Care And The Need For Doctor Visits
  Presenter(s):Tony S. Das, MD  
  View Slides in PDF      
1:34 PM - 1:39 PM New Evidence That Telehealth Virtual Visits Can Change Patient Behavior And Be Beneficial
  Presenter(s):John (Jeb) W. Hallett, MD  
  View Slides in PDF      
1:40 PM - 1:45 PM Lessons Learned By A Creative Physician-Inventor And How Artificial Intelligence Will Change Vascular Practice And The World
  Presenter(s):Lindsay Machan, MD  
  View Slides in PDF      
1:46 PM - 1:51 PM Relevance Of Cybersecurity And Artificial Intelligence To Endovascular Treatments
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
1:52 PM - 1:57 PM How To Use Apps To Improve Vascular Surgery And A Vascular Surgeon’s Practice
  Presenter(s):Keith D. Calligaro, MD  
  View Slides in PDF      
1:58 PM - 2:06 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: VASCULAR SURGERY BRANDING, RECOGNITION, TRAINING AND GOVERNING BODIES (BOARD AND RESIDENCY REVIEW COMMITTEE [RRC])
x
2:06 PM - 2:11 PM Vascular Surgeons Should Be Complete Vascular Doctors And Not Just Proceduralists: They Should Be Knowledgeable In And Manage All Aspects Of Non-Cardiac Vascular Disease Care
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
2:12 PM - 2:17 PM Update On Vascular Surgery Training Programs: Number Of 0+5 Positions; Number Of 5+2 Programs: How Many More Of Each Are In The Pipeline
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM How Medical/Hospital Executives Perceive Vascular Surgery: It Is Not As A Separate Specialty: Why We Need To Be A Separate Specialty And To Have The Recognition That Goes With It
  Presenter(s):Jeffrey H. Hsu, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Are Interventional Cardiologists Competing With Vascular Surgeons: What Are Their Advantages And Disadvantages: What Can Be Done About This Competition
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Why Vascular Surgery Needs An Approved Independent Board And To Be An Independent Specialty: Status Of The American Board of Vascular Surgery Or ABVS And What Progress Is It Making In Its Quest
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
2:36 PM - 2:41 PM The Reasons Why Vascular Surgery Needs To Be An Independent Specialty With Its Own Separate Board And RRC: It Is Time To Move From Being A Colony To A Nation, Or A Territory To A State
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
2:42 PM - 2:47 PM Vascular Surgery Needs An Independent ABMS Approved Board And RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM Vascular Surgery Needs Its Own Separate Approved Board And Qualifies For It In Every Way: However, To Get It The Specialty’s Leadership Represented By The SVS Executive Committee Must Recognize This Need And Go After It With Full Force
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
2:54 PM - 2:59 PM What Is Wrong With The American Board of Surgery’s MOC (Maintenance Of Certification) System For Vascular Surgeons And What Can Be Done To Fix It
  Presenter(s):K. Craig Kent, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM The Present MOC System Is Flawed And Does Not Help Patients: MOC Should Be Abolished And Replaced By A Lifelong Learning System: How To Do It
  Presenter(s):Gilbert R. Upchurch, MD  
  View Slides in PDF      
3:06 PM - 3:15 PM Panel Discussion
3:15 PM - 3:26 PM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: NEW DEVELOPMENTS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
x
3:26 PM - 3:30 PM [SS] Endovascular Treatment Of Large Renal Aneurysms With An Uncovered Stent Excludes The Aneurysm While Preserving Branch Flow: Does It Work
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
3:30 PM - 3:34 PM [SS] An Occluded Renal Artery Does Not Mean A Lost Kidney Due To Collaterals Maintaining Its Viability: Revascularization Can Restore Function
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
3:34 PM - 3:39 PM Renal Artery Aneurysms: When Are They Dangerous: Endovascular Techniques For Treatment: When Is Open Repair Indicated
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
  View Slides in PDF      
3:40 PM - 3:45 PM Endovascular Versus Open Treatment For Renal And Visceral Artery Aneurysms: When Is Each Treatment Best; Technical Tips
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
3:46 PM - 3:51 PM Update On Optimal Treatment For Acute Mesenteric Ischemia: When Endo; When Open: Technical Tips
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
3:52 PM - 3:57 PM Isolated Dissection Of The Celiac Axis Or Superior Mesenteric Artery (SMA) May Be Symptomatic Or Asymptomatic: Natural History And How Best To Treat
  Presenter(s):I-Hui Wu, MD, PhD  
  View Slides in PDF      
3:58 PM - 4:03 PM Panel Discussion
4:03 PM - 4:07 PM [SS] DEBATE: Open Surgery Has An Important Role In The Treatment Of Mesenteric Aneurysms
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
4:08 PM - 4:12 PM [SS] DEBATE: Not So: Mesenteric And Renal Aneurysms Can All Be Treated Endovascularly: Technical Tips
  Presenter(s):Robert A. Morgan, MD  
  View Slides in PDF      
4:13 PM - 4:18 PM Pancreaticoduodenal Artery Aneurysms: New Insights Into Their Natural History And Treatment: Endo Versus Open
  Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD  
  View Slides in PDF      
4:19 PM - 4:24 PM Embolization Treatment For Splenic Artery Aneurysms: When, When Not, Technical Tips And Long-Term Results
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
4:25 PM - 4:30 PM Indications And Technical Tips For Safe Retrograde SMA Stenting In Acute Mesenteric Ischemia: Best Access Is Via A Small SMA Branch
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
4:31 PM - 4:35 PM [SS] Direct Percutaneous Approach To Treat Visceral Artery Aneurysms Difficult To Approach Intraluminally: How To Do It Safely
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
  View Slides in PDF      
4:36 PM - 4:42 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: UPDATE ON OPEN SURGICAL AND HYBRID PROCEDURES; NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC COARCTATION
x
4:42 PM - 4:47 PM Can Simulation Substitute For The Decrease In Open Aortic Cases In Training And Practice
  Presenter(s):Ashraf Mansour, MD  
  View Slides in PDF      
4:48 PM - 4:53 PM When Is Open Surgery The Best Treatment For Visceral Occlusive Disease And Aneurysms And Why
  Presenter(s):Laurent Chiche, MD, FEBVS  
  View Slides in PDF      
4:54 PM - 4:59 PM Technical Tips For Obtaining Open Retroperitoneal Exposure For Treating Complex AAAs Involving The Pararenal And Visceral Aorta
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM Long-Term Results Of Open Juxta- And Pararenal AAA Repair: From A Large Multicenter National Database With Mean Follow-Up Of 4 Years
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
5:06 PM - 5:11 PM Durability And Late Results Of TAAA Repairs For Type IV And Types I-III TAAAs: When Should Open Repair Be The Preferred Treatment In The Current Endo World
  Presenter(s):Hazim J. Safi, MD  
  View Slides in PDF      
5:12 PM - 5:17 PM Minimal Incisions For Open Aortobifemoral And Fempop Bypasses: Technical Tips And Advantages
  Presenter(s):Robert M. Proczka, MD, PhD  
  View Slides in PDF      
5:18 PM - 5:23 PM Panel Discussion
5:24 PM - 5:29 PM Is There Still A Role For Hybrid Procedures In The Endo Era: Why And In What Conditions And Vascular Beds
  Presenter(s):Oscar L. Ojeda, MD, FACS  
  View Slides in PDF      
MID-AORTIC SYNDROME
5:30 PM - 5:35 PM Update On Revascularization For Renovascular Hypertension And Mid-Aortic Syndrome: It Is Almost Always Best Treated By Open Surgery
  Presenter(s):Dawn M. Coleman, MD  
  View Slides in PDF      
5:36 PM - 5:41 PM Renovascular Hypertension And Mid-Aortic Syndrome: There Is A Role For Endovascular As Well As Open Treatments: Which Treatment Is Best At What Ages
  Presenter(s):George Hamilton, MD, FRCS  
  View Slides in PDF      
ADVANCES IN COARCTATION TREATMENT
5:42 PM - 5:47 PM Advances In Covered Stent Treatment Of Aortic Coarctation: Value Of New Balloon Expandable Stent-Grafts: Are Bare Stents Ever Indicated
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
5:48 PM - 5:53 PM Tips And Tricks For Endo Treatment Of Aortic Coarctation With Aneurysmal Degeneration As A Complication Of A Chronic TBAD
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
5:54 PM - 6:00 PM Panel Discussion
End of Program B
END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH - PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism—What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
7:25 AM - 7:35 AM Do We Need An Echo To Manage Acute Submassive PE
  Presenter(s):David M. Dudzinski, MD  
  View Slides in PDF      
7:35 AM - 7:45 AM Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE
  Presenter(s):Brian B. Ghoshhajra, MD, MBA  
  View Slides in PDF      
7:45 AM - 8:00 AM Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
  View Slides in PDF      
8:00 AM - 8:10 AM Testing For Cancer And Other Hypercoagulable States In PE
  Presenter(s):Rachel Rosovsky, MD, MPH  
  View Slides in PDF      
8:10 AM - 8:20 AM The First Opportunity—The Emergency Physician Algorithm For Acute PE Management
  Presenter(s):Rachel Rosovsky, MD, MPH / D. Mark Courtney, MD  
8:20 AM - 8:35 AM Intravenous Thrombolytic Therapy For PE: No Need For Catheter-Based Intervention
  Presenter(s):Jay Giri, MD, MPH  
  View Slides in PDF      
8:35 AM - 8:45 AM Advancing The Science In PE Treatment—What Do We Need To Know, And How Will We Learn
  Presenter(s):Akhilesh K. Sista, MD  
  View Slides in PDF      
8:45 AM - 8:55 AM Ultrasound-Assisted Pharmacomechanical Thrombectomy—Does This Really Work
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
8:55 AM - 9:05 AM What Device Is Best For Acute PE Intervention
  Presenter(s):James F. Benenati, MD  
  View Slides in PDF      
9:05 AM - 9:15 AM Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
9:15 AM - 9:25 AM Percutaneous Mechanical Thrombectomy Without Lytics: The Results Of The FLARE Study
  Presenter(s):Thomas M. Tu, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
9:25 AM - 9:45 AM Panel Discussion
  Panelist(s): Gary M. Ansel, MD / James F. Benenati, MD / David M. Dudzinski, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Manish Mehta, MD, MPH / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / Akhilesh K. Sista, MD / Thomas M. Tu, MD  
9:45 AM - 10:10 AM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 2
Moderators:Michael R. Jaff, DO  
x
10:10 AM - 10:20 AM Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
10:20 AM - 10:30 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD, MBA  
  View Slides in PDF      
10:30 AM - 10:40 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
10:40 AM - 10:55 AM Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
10:55 AM - 11:10 AM Vena Cava Filters In PE Treatment—Do We Need To Do This, And If So, When
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
11:10 AM - 11:25 AM Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension—Has This Become Mainstream
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
11:25 AM - 11:35 AM The Team Approach To PE Management: The National PERT Consortium
  Presenter(s):Richard N. Channick, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
11:35 AM - 12:00 PM Challenging Cases And “PERT” Decisions
  Panelist(s): Gary M. Ansel, MD / Richard N. Channick, MD / Mark G. Davies, MD / Christopher J. Kwolek, MD, MBA / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Kenneth Rosenfield, MD / Ido Weinberg, MD, MSc  
  View Slides in PDF      
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
End of Program C-1
END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: INTRODUCTION TO VASCULAR MALFORMATIONS
x
1:00 PM - 1:02 PM Welcome
  Presenter(s):Krassi Ivancev, MD, PhD  
1:02 PM - 1:07 PM The International Society for the Study of Vascular Anomalies Classification System for Vascular Malformations
  Presenter(s):Fiona Rohlffs, MD  
  View Slides in PDF      
1:08 PM - 1:13 PM Pediatric Hemangioma And Propranolol Medical Management
  Presenter(s):Laurence M. Boon, MD, PhD  
1:14 PM - 1:19 PM The Palliative Role Of Sirolimus In Vascular Malformation Management
  Presenter(s):Laurence M. Boon, MD, PhD  
1:20 PM - 1:28 PM Ethanol Sclerotherapy Of Hepatic Venous Malformations
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
1:29 PM - 1:37 PM Ethanol Sclerotherapy Of Complex Peripheral Venous And Lymphatic Malformations
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: HEAD AND NECK VASCULAR MALFORMATION MANAGEMENT; HIGH-FLOW AVMs MANAGEMENT ISSUES
x
1:38 PM - 1:46 PM Endovascular Ethanol Sclerotherapy Of Complex Head & Neck Venous And Lymphatic Malformations
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
1:47 PM - 1:55 PM Combined Endovascular And Surgical Management Of Head & Neck Vascular Malformations
  Presenter(s):Laurence M. Boon, MD, PhD  
1:56 PM - 2:04 PM Direct Laryngoscopy In The Diagnosis And Treatment Of Vascular Malformations
  Presenter(s):Edward J. Hepworth, MD  
2:05 PM - 2:13 PM Curative Endovascular Management Strategies Of Complex/Multiple Head & Neck AVMs
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
HIGH-FLOW AVMs MANAGEMENT ISSUES
Moderator(s): Tarek M.S. Radwan, FRCS / Edward J. Hepworth, MD  
2:14 PM - 2:25 PM The Yakes AVM Classification System: A Guide To Curative Endovascular Treatment Strategies
  Presenter(s):Fiona Rohlffs, MD  
  View Slides in PDF      
2:26 PM - 2:33 PM Where Is The AVM Nidus
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
2:34 PM - 2:41 PM Complex Capillary-Venous Malformations And Their Endovascular Management
  Presenter(s):Tarek M.S. Radwan, FRCS  
  View Slides in PDF      
2:42 PM - 2:49 PM The Retrograde Vein Approach For Curative Endovascular Treatment Of AVMs
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
2:50 PM - 3:00 PM Endovascular Treatment Of Intraosseous Vascular Malformations
  Presenter(s):Fiona Rohlffs, MD  
  View Slides in PDF      
3:00 PM - 3:00 PM End of Program C-2
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ¾ MINUTES)
x
3:00 PM - 3:05 PM New Performance Goals For SFA Endovascular Treatments: How Good Are Current Devices: From The RAPID Multispecialty Registry
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
3:05 PM - 3:10 PM 12 Commandments For Successful BTK Endovascular Interventions In Patients With Chronic Limb Threatening Ischemia (CLTI)
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
3:10 PM - 3:15 PM DEBATE: With Extensive Foot Gangrene From CLTI, Multivessel Endo Intervention Is The Best Treatment
  Presenter(s):Vikram S. Kashyap, MD / Norman Kumins, MD / Mehdi H. Shishehbor, DO, MPH, PhD  
  View Slides in PDF      
3:15 PM - 3:20 PM DEBATE: Not So: With Extensive Foot Gangrene From CLTI A Vein Bypass To A Single Good Outflow Artery Is The Best Treatment
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
3:20 PM - 3:25 PM Optimal Treatment Of Diabetics With CLTI And Extensive Ulceration/Gangrene: When Endo, When Open Bypass: What Is The Best Timing For Foot Debridement
  Presenter(s):Katariina M. Noronen, MD, PhD  
  View Slides in PDF      
3:25 PM - 3:30 PM Panel Discussion
3:30 PM - 3:35 PM Where Do We Stand With Below The Knee (BTK) Drug Coated Balloons (DCBs): What Is Their Future And What Are Open Questions
  Presenter(s):Marc Bosiers, MD  
  View Slides in PDF      
3:35 PM - 3:40 PM New Devices To Facilitate Lower Extremity Endo Treatments And Crossing Of Chronic Total Occlusions (CTOs): A 4 Fr Catheter With A Retractable Needle – The Go Back Crossing Catheter (Upstream Peripheral) And The Bullfrog Device For Injecting Local Anesthesia In The Artery Wall: How Do They Work
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
3:40 PM - 3:45 PM Spot Stenting Using Multiple Short Stents For Long SFA/Pop Lesions (Vascuflex Multiloc Device From B. Braun Medical): How Does It Work And Results
  Presenter(s):Erwin Blessing, MD / Thomas Zeller, MD  
  View Slides in PDF      
3:45 PM - 3:50 PM Drug Delivery In BTK Arteries: Where Does It Stand: Where Is It Going: What Are Some New Drug Delivery Concepts
  Presenter(s):Dierk Scheinert, MD  
  View Slides in PDF      
3:50 PM - 3:55 PM The Challenge Of Treating Extensively Calcified Lesions In CLTI Patients And How To Overcome The Problem
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM Panel Discussion
4:00 PM - 4:05 PM DEBATE: An Endo First Approach Is Best For All CLTI Patients And Does Not Burn Bridges If An Open Bypass Is Required Later
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
4:05 PM - 4:10 PM DEBATE: Not True: Patient First Is Better: Endo First Does Not Work For All CLTI Patients: Target Arteries For Later Open Bypass Can Be Damaged (Bridges Burned)
  Presenter(s):Philip P. Goodney, MD, MS  
  View Slides in PDF      
4:10 PM - 4:15 PM Long-Term (5 Years) Effectiveness Of Zilver PTX Drug Eluting Stents (DESs) For Fempop In Stent Restenosis (ISR): From The Japanese Post Market Surveillance Study
  Presenter(s):Kimihiro Komori, MD, PhD  
  View Slides in PDF      
4:15 PM - 4:20 PM The “Balloon Wrap” Issue As A Cause Of Dissections With Balloon Angioplasty (PTA): What Is It And Which Balloons Are Least Affected By It
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
4:20 PM - 4:25 PM Update On The Value Of Toe Pressures, Statins And Clopidogrel In CLTI: Why They Matter
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
4:25 PM - 4:30 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ¾ MINUTES)
x
4:30 PM - 4:35 PM Character And Localization Of Arterial Calcification Pathologically: What Are The Implications For Endo Treatments
  Presenter(s):Renu Virmani, MD  
  View Slides in PDF      
4:35 PM - 4:40 PM Significance Of Calcification In Lower Extremity Arteries Clinically: How To Evaluate It: What Does It Mean For Endo Treatments
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
4:40 PM - 4:45 PM DESs Versus DCBs: Which Is Best When: Which Is More Cost Effective
  Presenter(s):Mohammad H. Eslami, MD, MPH  
  View Slides in PDF      
4:45 PM - 4:50 PM DEBATE: When Common Femoral Artery (CFA) Lesions Need Treatment, Open Endarterectomy Is The Procedure Of Choice
  Presenter(s):Matthew T. Menard, MD  
  View Slides in PDF      
4:50 PM - 4:55 PM DEBATE: Not So: CFA Lesions Are Best Treated By Angioplasty And Stenting: 2-Year Results With The Supera Stent (Vasculomimetic Implant [VMI] From Abbott)
  Presenter(s):Yann Gouëffic, MD, PhD / Koen R. Deloose, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM Stenting Of CFA Lesions Compares Favorably To Endarterectomy In A RCT (TECCO Trial) Even When The Distal Bifurcation Is Involved: The Culotte Technique For Stenting Both CFA Branches
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
5:00 PM - 5:05 PM 2-Year Results Of The ZILVER PASS RCT Comparing Zilver PTX DES Treatment To Open Prosthetic Bypasses For Long Fempop Lesions: Patency Is Equal But Complications And Length Of Stay Less With Zilver PTX
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
  View Slides in PDF      
5:05 PM - 5:10 PM Distal Bypasses Can Save Limbs With Extensive Gangrene And Calcified Arteries In Dialysis Patients: Key Technical Tips
  Presenter(s):Nobuyoshi Azuma, MD  
  View Slides in PDF      
5:10 PM - 5:15 PM Panel Discussion
5:15 PM - 5:20 PM 5-Year Follow-Up Outcomes And Lessons Learned From The In.Pact Deep DCB RCT For BTK Lesions: Managing CLTI Patients Is Challenging
  Presenter(s):Jos C. van den Berg, MD, PhD / Thomas Zeller, MD  
  View Slides in PDF      
5:20 PM - 5:25 PM Role Of New Stem Cell Therapies In Treating Lower Extremity Ischemia
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
5:25 PM - 5:30 PM How To Use CO2 As A Contrast Agent To Visualize Patent Foot Arteries In CLTI Patients
  Presenter(s):Jim Caridi, MD, FSIR  
  View Slides in PDF      
5:30 PM - 5:35 PM Technical Tips For Using CO2 As A Contrast Agent To Image Patent Tibial And Foot Arteries Better And Safely
  Presenter(s):Palma M. Shaw, MD  
  View Slides in PDF      
5:35 PM - 5:40 PM Value Of Adequate Vessel Prep And Duplex Imaging In Optimizing Results Of Balloon And DCB Angioplasty In Crural (Tibial) Arteries – Especially With Long Lesions
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
5:40 PM - 5:45 PM Nanotechnology: A New Frontier In The Imaging And Treatment Of CLTI
  Presenter(s):Sean C. Morris, BSci  
  View Slides in PDF      
5:45 PM - 5:50 PM Infrainguinal Bypasses After Failed Endovascular Treatments Have Lower Patency And Higher Amputation Rates Than Primary Bypasses
  Presenter(s):Alik Farber, MD  
  View Slides in PDF      
5:50 PM - 5:55 PM Extensive Heel Gangrene With CLTI Is Not A Contraindication To Limb Salvage: How To Save The Limb In This Setting
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
5:55 PM - 6:00 PM Panel Discussion
End of Program C-3

END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
x
6:40 AM - 6:45 AM Understanding US FDA IDEs (Investigative Device Exemptions) Trials For Evaluating Lower Extremity Endo Devices – Especially BTK Devices: What These Will Tell Us (About Patency) And What They Won’t Tell Us (About Amputation Free Survival)
  Presenter(s):Patrick J. Geraghty, MD  
  View Slides in PDF      
6:46 AM - 6:51 AM Optimal Techniques For Vessel Preparation Before Deployment Of A Drug Coated Or Uncoated Balloon Or Stent
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM Value Of IVUS In Lower Extremity Endovascular Treatments: It Is A Management-Altering, Must Have Game Changer
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
6:58 AM - 7:03 AM Which Wires And Catheters Are Best To Reach Infrainguinal Arteries Via A Radial Approach: Innovative New Wire Engineering Designs To Improve Performance Of 104 Wires: What Is A Twist Wire And How Does It Work
  Presenter(s):Craig M. Walker, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM Endovascular Treatment Is Appropriate For CLTI Patients With Heel Gangrene Involving The Os Calcis And Achilles Tendon: Limb Salvage With Function Can Be Achieved And How
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM What Is The Future Of Stenting In The Current DCB World: DCBs Do Not Always Work For Complex Lesions: Leave Nothing Behind Is Only A Dream
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
  View Slides in PDF      
SOME COMMENTS ON ENDOVASCULAR TREATMENTS OF ARTERIAL LESIONS IN THE FOOT
7:16 AM - 7:21 AM How Durable Is The Patency Of Balloon Angioplasty Of Foot Arteries And Plantar Loop Procedures: Why It May Not Matter
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM Should We Treat Foot Vessel Lesions Or Is Such Treatment Fanciful Or Harmful: How Should We Monitor Such Treatment: What Is The End Point And When Is Open Surgery Better
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM Small Artery Disease (SAD) And Medial Artery Calcification (MAC) In The Foot: What Is Its Role In Severe CLTI And How Is It Best Treated
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
7:34 AM - 7:39 AM Open Bypass To Foot Arteries Can Save Limbs If Foot Arteries And Arches Have Not Been Instrumented: A Note Of Caution
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
7:40 AM - 7:45 AM Role Of Distal Bypass In CLTI With Severe Gangrene: What % Of Such Patients Will Need One At Some Time In Their Course: When Are Pedal Bypasses Better Than Pedal Loop Procedures
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
7:46 AM - 7:52 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: PROGRESS IN STENT BASED TREATMENTS, ATHERECTOMY AND LITHOPLASTY (LITHOTRIPSY) FOR LOWER EXTREMITY OCCLUSIVE LESIONS
x
7:52 AM - 7:57 AM DCBs Versus DESs: Advantages And Disadvantages Of Each: Why DCBs Should Be First Line Therapy For Most Lesions In Most Patients
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM For Fempop Lesions, Zilver PTX DESs Are Durable Effective Treatment: 5-Year Results Show It Even In Adverse Circumstances: New Findings From The Zilver PTX RCT
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Which Patients With Fempop Occlusive Lesions Are Not Candidates For DCB Treatment: How Should They Be Treated
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
8:10 AM - 8:15 AM New Findings From The IMPERIAL RCT Comparing Zilver PTX DESs With Eluvia DESs For Fempop Lesions: Do Differences In Technology And Results In High Risk Subgroups Suggest That Eluvia Is A Better Stent
  Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Not Sure That IMPERIAL RCT To Date Shows Differences That Are Important: Zilver PTX Is Still A Good DES With Favorable Longer-Term Results And Both Stents Produced Equal Improvement In Symptoms
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM Another View On When To Use Which Stent For Fempop Lesions: Supera, Zilver PTX, Eluvia Or Others
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
8:28 AM - 8:33 AM Eluvia (Boston Scientific) Is The Only Polymer Based Paclitaxel DES Technology, And It Is Now Being Studied For BTK Lesions In The SAVAL RCT
  Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Bioresorbable Everolimus DESs For Treating BTK Lesions: The Results With The Absorb Stent (Abbott) Were Favorable For 5 Years: What Does The Future Hold For Such Stents
  Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
  View Slides in PDF      
8:40 AM - 8:45 AM Current Status And Improvements In Atherectomy Devices: Which One Or Ones Are Best And Why: For Stand-Alone Treatment Or For Vessel Preparation For Other Treatments
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
8:46 AM - 8:51 AM Which Atherectomy Device Is Best And Why; A European Perspective And Shockwave Based Technology With A Jack-Hammer Effect To Facilitate CTO Wire Crossing (From Soundbite Medical Solutions); How It Works
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
8:52 AM - 8:57 AM Update On Intravascular Lithotripsy (Lithoplasty) To Treat Calcified Occlusive Lesions: When Is It Worthwhile And When Not: From The DISRUPT PAD Trials And The REAL World Registry
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
8:58 AM - 9:02 AM Late Breaking 5-Year Results Of Bioresorbable DES (Abbott) For BTK Lesions: Future Implications
  Presenter(s):Brian G. DeRubertis, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
  View Slides in PDF      
9:02 AM - 9:10 AM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: NEW DEVELOPMENTS IN LOWER EXTREMITY RELATED TOPICS: DOWNSIDE OF DCBs: THE PACLITAXEL COATED DEVICES INCREASE MORTALITY ISSUE
x
9:10 AM - 9:15 AM Introductory Remarks And Overview
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
9:16 AM - 9:21 AM The Downsides To DCBs: Cost; Distal Embolization; Increased Mortality: Are They Substantive
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
9:22 AM - 9:27 AM Update On The Meta-Analysis Showing An Increased Mortality In Patients Treated With Drug (Paclitaxel) Coated Lower Extremity Devices (DCBs And DESs): What Is The Current Interpretation
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
9:28 AM - 9:33 AM Understanding The Pharmacology, Mechanisms Of Action And Toxicity Of Paclitaxel On Drug Coated Devices: How Could Paclitaxel Influence Mortality
  Presenter(s):Juan F. Granada, MD  
  View Slides in PDF      
9:34 AM - 9:39 AM Is The Increased Mortality Risk Of Paclitaxel Coated Lower Extremity Devices Observed In The Meta-Analysis Real And Meaningful: Update From The VIVA Leaders Analysis: Currently How Should It Influence Use Of These Devices: Where Is This Issue Going
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM Current Status Of The Discussion On Paclitaxel Coated Lower Extremity Devices And Their Impact On Patient Mortality: Another View And Where Does The FDA Stand And Why
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
9:46 AM - 9:51 AM What Is The Society for Vascular Surgery (SVS) Doing About This Issue And Where Does It Stand On It
  Presenter(s):Kim J. Hodgson, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM What Is The Response To And Position Of An Industry Partner (Medtronic) Which Is Vested In Drug Eluting Technology
  Presenter(s):Mark Pacyna  
  View Slides in PDF      
9:58 AM - 10:03 AM Update On The Late Results (> 5 Years) Of The Zilver PTX DES Trials That Are Relevant To This Issue: Including The Corrected Late Patient Mortality Data
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
10:04 AM - 10:09 AM Long-Term Safety And Effectiveness Of Paclitaxel Coated Devices Versus Non-Coated Devices For Fempop Occlusive Lesions: From Japanese RCTs And Registries: How Do These Data Bear On The Paclitaxel-Mortality Issue
  Presenter(s):Osamu Iida, MD / Hiroyoshi Yokoi, MD  
  View Slides in PDF      
10:10 AM - 10:15 AM 6-Year Comparison Of Mortality And Its Causes In 1500 Patients Treated With Paclitaxel Coated DCBs Or DESs Versus Bare Metal Stents (BMSs) Or Plain Old Balloon Angioplasty (POBA)
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
10:16 AM - 10:19 AM Large Population Based Multicenter German Study Indicates Paclitaxel Coated Devices May Be Associated With Lower Late Mortality Than Uncoated Devices In Some Patient Subgroups
  Presenter(s):Christian A. Behrendt, MD  
  View Slides in PDF      
10:19 AM - 10:25 AM Panel Discussion
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND OTHER DEVICES FOR TREATING LOWER EXTREMITY OCCLUSIVE LESIONS; RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK TREATMENTS (5- AND 4-MINUTE SHORT SUMMARY [SS] TALKS)
x
10:25 AM - 10:30 AM Present Status And Future Potential Of DCBs: Is Durability Maintained: Preventing Restenosis And Catch-Up: Importance Of Dual Antiplatelet Agents
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
10:31 AM - 10:36 AM Best Current Treatment For Long Complex Lesions Is DCBs With Provisional Stenting: What Is The Evidence
  Presenter(s):John R. Laird, MD  
  View Slides in PDF      
10:37 AM - 10:42 AM The REAL PTX RCT Compares DESs Versus DCBs For Treating Fempop Lesions, Some Long And Complex: At 2 Years, Results Are Better With DESs
  Presenter(s):Andrej Schmidt, MD / Yvonne Bausback, MD  
  View Slides in PDF      
10:43 AM - 10:48 AM 5-Year Results From The IN.PACT SFA RCTs Shows Maintained Benefit Of In.Pact DCB Versus POBA For Treatment Of SFA Lesions With No Increase In Complications Or Mortality
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD  
  View Slides in PDF      
10:49 AM - 10:54 AM The Real World GLOBAL REGISTRY Confirms The Value Of The In.Pact DCB For Treating More Complex SFA Lesions Including In Stent Restenosis (ISR)
  Presenter(s):Marianne Brodmann, MD / Gary M. Ansel, MD / Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
10:55 AM - 11:00 AM 2-Year Results Of The COMPARE PILOT RCT Comparing The Ranger DCB (Boston Scientific) With The In.Pact DCB (Medtronic) For Treating Complex Fempop Lesions And 12-Month Results Of Ranger II Trial
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD / Marianne Brodmann, MD  
  View Slides in PDF      
11:01 AM - 11:06 AM Safety And Effectiveness Of The Stellarex DCB (Philips) With Low Dose Paclitaxel Up To 3 Years In The Treatment Of Fempop Occlusive Lesions
  Presenter(s):Fabrizio Fanelli, MD, EBIR / Sean P. Lyden, MD  
  View Slides in PDF      
11:07 AM - 11:12 AM Panel Discussion
BELOW THE KNEE DCBs
11:13 AM - 11:18 AM The ACO ART II RCT Shows Favorable Results With The Orchid DCB To Treat BTK Lesions: With The Right DCB Technology The Future For BTK DCBs Is Brighter Than The Past
  Presenter(s):Francesco Liistro, MD / Wei Guo, MD  
  View Slides in PDF      
11:19 AM - 11:24 AM Results Of A RCT Show The Lutonix DCB (Becton Dickinson/Bard) To Be Better Than POBA For BTK Occlusive Lesions
  Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM Value Of The Stellarex DCB (Philips) For Treating BTK Occlusive Lesions: The ILLUMINATE BTK Trial
  Presenter(s):Craig M. Walker, MD / Mahmood Razavi, MD  
  View Slides in PDF      
11:31 AM - 11:36 AM Update On SurVeil DCBs (Surmodics/Abbott) For Treating BTK Lesions: What Makes This DCB Different: 1-Year Safety And Efficacy From The PreVail Trial
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
11:37 AM - 11:42 AM Economic Factors In The Treatment Of CLTI: Are Drug Coated Balloons (DCBs) DESs Stents Cost Effective: How Can The Costs Of Devices Be Met
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
11:43 AM - 11:48 AM What Is The Importance Of Dual Antiplatelet Agents To The Success Of DCBs And What Is The Current Status Of DCBs With Drugs Other Than Paclitaxel
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
SHORT SUMMARY 4-MINUTE TALKS
11:49 AM - 11:53 AM [SS] Value Of A Scoring Balloon (Ultrascore From Becton Dickinson/Bard) In Vessel Preparation Before DCB Use In Fempop Lesions: How It Works And Experience To Date
  Presenter(s):Marcus Thieme, MD / Dierk Scheinert, MD  
  View Slides in PDF      
11:53 AM - 11:57 AM [SS] DEBATE: SFA Endovascular Treatment Durability Does Not Require Drug Eluting Devices: The Evidence
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
11:57 AM - 12:01 PM [SS] DEBATE: Not So: Drug Elution Is Essential For SFA Endovascular Treatments To Be Effective And Durable
  Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD  
  View Slides in PDF      
12:01 PM - 12:06 PM Panel Discussion
12:06 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY OCCLUSIVE DISEASE CAUSING SEVERE CHRONIC LIMB THREATENING ISCHEMIA (CLTI): HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
x
1:00 PM - 1:05 PM How To Gain Retrograde Arterial Access Via Leg Arteries: The Tibioperoneal Trunk, Peroneal, Posterior Tibial And Anterior Tibial: Equipment And Technical Tips
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM ‘Fancy’ Techniques For Getting A Guidewire Across Difficult Chronic Total Occlusions – Especially Those In BTK Arteries In CLTI Patients
  Presenter(s):Osamu Iida, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM No Option CLTI: The “Desert Foot”: An Increasing Epidemic: An Overview Of Solutions For It And How To Salvage Some Of These Limbs
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Extreme Distal Lower Limb Revascularization: Durable Solution Or Technical Show Off: Distal Access, Plantar Loop Procedures And Subintimal Angioplasty In Foot Arteries: What Is Their Impact On Mid And Long-Term Results
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR / Michel Rossi, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Treatment Possibilities For “No Option” Patients: Including The Pros And Cons Of Venous Arterialization
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
UPDATE ON VENOUS ARTERIALIZATION
1:30 PM - 1:35 PM Surgical Arterialization Of Foot Veins For No Option CLTI: How To Do It And Long-Term Outcomes: From A Pioneer
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Slides in PDF      
1:36 PM - 1:41 PM Arterialization Of Foot Veins Can Save Limbs With No Option CLTI: How And Why Does It Work And Why Does It Fail: What Is Hybrid Arterialization Of Foot Veins: How Does It Compare To The LimFlow Totally Endo Procedure
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Update On Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For No Option CLTI: Techniques And Results
  Presenter(s):Steven Kum, MD / Daniel G. Clair, MD / Jihad A. Mustapha, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Panel Discussion
1:53 PM - 1:58 PM Tibial Bypasses With PTFE Grafts Are Worthwhile (When Autologous Vein Is Lacking) In Hopelessly Threatened Limbs And Can Save A Functional Limb For Many Years: They Deserve A Better Reputation Than They Have
  Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Neal S. Cayne, MD / Evan C. Lipsitz, MD, MBA / Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Frank J. Veith, MD  
  View Slides in PDF      
1:59 PM - 2:04 PM Ultradistal Bypasses To Below The Ankle Arteries Can Save Limbs With CLTI And Gangrene: How Distal In The Foot Can One Go: No Option CLTI Is Usually A Misnomer
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
2:05 PM - 2:10 PM Extended Open Techniques To Save Threatened Feet When All Endovascular Attempts Have Failed
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
2:11 PM - 2:16 PM Below The Ankle Angioplasty And Stenting For CLTI: Technical Tips, Indications And Challenges: Poor Patency Rates May Not Hamper Limb Salvage
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
2:17 PM - 2:22 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN LOWER EXTREMITY IN STENT RESTENOSIS (ISR); SELF-EXPANDING STENT-GRAFTS (VIABAHN); HEPARIN BONDING; ARTERIAL CALCIFICATION; UNUSUAL LOWER EXTREMITY STENTS AND THE IMPORTANCE OF HEPARIN BONDING TO PTFE GRAFTS AND DCB INFLATION PRESSURES (SEE ALSO SESSION 59)
x
IN STENT RESTENOSIS (ISR)
2:22 PM - 2:27 PM Update On Best Current Treatment For In Stent Restenosis (ISR): A European Perspective
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
2:28 PM - 2:33 PM Update On The Best Current Treatment For ISR Of Varying Grades: A US Perspective
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
2:34 PM - 2:39 PM A Different View Of Optimal Treatment For Varying Grades Of ISR: When Is A Stent-Graft The Best Treatment
  Presenter(s):Marc Bosiers, MD  
  View Slides in PDF      
NEW DEVELOPMENTS IN VALUE OF SELF-EXPANDING STENT GRAFTS (VIABAHN)
2:40 PM - 2:45 PM Update On Value And Indications Of The Viabahn Self-Expanding Stent-Graft For Fempop Occlusive Disease: Evolution Of The Device: Technical Tips And 5-Year Results From Japan
  Presenter(s):Osamu Iida, MD  
  View Slides in PDF      
2:46 PM - 2:51 PM Value Of Viabahn Stent-Grafts To Treat Failing And Failed Fempop Grafts: Technical Tips And Results
  Presenter(s):Naoki Fujimura, MD, PhD  
  View Slides in PDF      
2:52 PM - 2:57 PM Comparison Of Endoluminal Bypass With Viabahn Stent-Grafts Versus Supera Vasculomimetic Stents For Treating Fempop Occlusive Lesions: Indications For And Advantages And Limitations Of Each: When Is An Open Bypass Necessary
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
2:58 PM - 3:03 PM Panel Discussion
PTFE-HEPARIN BONDING
3:03 PM - 3:08 PM Comparison Of Heparin Bonded PTFE Grafts To Those Without Heparin Bonding
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
THE DETOUR PROCEDURE
3:09 PM - 3:14 PM Percutaneous (PQ) Transvenous Endovascular Fempop Arterial Bypass For Treating Long (30-40 cm) SFA Occlusions: How Does It Work And 2-Year Results: From The DETOUR Trials
  Presenter(s):Sean P. Lyden, MD  
  View Slides in PDF      
3:15 PM - 3:20 PM Will The Detour Procedure For PQ Endovenous Fempop Arterial Bypass Eliminate The Need For Open Surgery: When Will It And When Won’t It
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
ARTERIAL CALCIFICATION
3:21 PM - 3:26 PM Types Of Arterial Calcification And How They Impede Balloon Angioplasty Of Occluded Tibial Arteries: How Can It Be Overcome: The DEKIAP (Direct Extravascular Kalcium Interruption Arterial Procedure): Technique And Results
  Presenter(s):Steven Kum, MD  
  View Slides in PDF      
UNUSUAL LOWER EXTREMITY STENTS
3:27 PM - 3:32 PM Initial Experience With A 3 French Compatible Microstent For Antegrade Or Retrograde Treatment Of Tibial Artery Lesions (From Micro Medical Solutions)
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
  View Slides in PDF      
3:33 PM - 3:38 PM 2-Year Results With The 3D Helical Stent That Induces Swirling Flow: The MIMICS-2 Trial Shows This Stent Works Well For Complex SFA Lesions (From Veryan Medical)
  Presenter(s):Timothy M. Sullivan, MD / Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
3:39 PM - 3:50 PM Panel Discussion
3:50 PM - 4:00 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: UPDATES ON LOWER EXTREMITY CLTI GUIDELINES, RCTs AND FOOT PERFUSION INDICATORS
x
4:00 PM - 4:10 PM What Is New And Good About The Recent Multispecialty Global Vascular Guidelines For CLTI: What Are Their Limitations And Why Is TASC Outdated
  Presenter(s):Michael S. Conte, MD / Andrew W. Bradbury, MD, FRCSEd / Philippe Kolh, MD  
  View Slides in PDF      
4:11 PM - 4:16 PM Update On The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endovascular Treatments; 3 Compares DCBs And DESs With POBA And Uncoated Stents
  Presenter(s):Andrew W. Bradbury, MD, FRCSEd  
  View Slides in PDF      
4:17 PM - 4:22 PM DEBATE: Progress In The BEST-CLI RCT Comparing Open And Endo Treatments: This Trial Will Provide Important New Information On The Best Treatment For CLTI
  Presenter(s):Alik Farber, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD  
  View Slides in PDF      
4:23 PM - 4:28 PM DEBATE: Sorry, BEST-CLI Does Not Reflect Real World Practice And Will Have Little Value In Guiding Best Treatment For CLTI Which Must Be Individualized
  Presenter(s):George L. Adams, MD / Miguel F. Montero-Baker, MD  
  View Slides in PDF      
4:29 PM - 4:34 PM The SPINACH Registry Shows That Open Bypass Is Better In CLTI With Extensive Gangrene: On The Other Hand, Endo First Is Better In High Risk Patients
  Presenter(s):Nobuyoshi Azuma, MD  
  View Slides in PDF      
4:35 PM - 4:40 PM How To Evaluate Below The Ankle Arteries And Occlusions: CTA And Standard Arteriography Is Inadequate And Some Patent Arteries Will Not Be Seen; Need Distal Interventional Arteriography: How To Do It
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
4:41 PM - 4:46 PM Surgery Guided Revascularization And Flow Guided Surgery: What Do They Mean And Why They Are Important To Saving Limbs: Optimal Timing And Type Of Surgery For Gangrene In CLTI: How To Get A Functional Limb
  Presenter(s):Giacomo Clerici, MD / Roberto Ferraresi, MD  
  View Slides in PDF      
4:47 PM - 4:52 PM How To Optimize Endovascular Treatment To Achieve Adequate Foot Perfusion To Heal Foot Wounds In CLTI: How To Measure It; What Are The Variables
  Presenter(s):Vikram S. Kashyap, MD / Mehdi H. Shishehbor, DO, MPH, PhD  
  View Slides in PDF      
4:53 PM - 4:58 PM Indocyanine Green Fluorescence (ICG-FL) Is The Best Way To Measure Foot Perfusion After Revascularization: Open Bypass Does Better Than Endo: Why The Angiosome Concept Is More Important After Endo Than Open Procedures
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
4:59 PM - 5:04 PM Pedal Temperature Measurements After Revascularization Will Indicate Healing Potential And Optimal Time For Foot Surgery: How To Standardize These Measurements And Make Them Valid
  Presenter(s):Wayne J. Caputo, DPM  
  View Slides in PDF      
5:05 PM - 5:11 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
x
INTERMITTENT CLAUDICATION (IC)
5:11 PM - 5:16 PM In Patients With IC From SFA Lesions, Stenting Plus Best Medical Treatment (BMT) Improved Quality Of Life And ABI More Than BMT Alone For 2 Years In An RCT
  Presenter(s):Hans Lindgren, MD, PhD  
  View Slides in PDF      
5:17 PM - 5:22 PM Why Most Patients With IC Due To SFA Lesions Should Not Undergo Stenting
  Presenter(s):Neal S. Cayne, MD  
  View Slides in PDF      
5:23 PM - 5:28 PM Endovascular Treatments For IC Can Lead To CLTI And Burn Bridges: Causes And Remedies
  Presenter(s):Niten Singh, MD  
  View Slides in PDF      
ACUTE LIMB ISCHEMIA (ALI)
5:29 PM - 5:34 PM Update On Newer Endovascular Thrombosuction Devices For ALI: When Is Open Treatment Required
  Presenter(s):Athanasios Katsargyris, MD  
  View Slides in PDF      
5:35 PM - 5:40 PM Thrombolysis For ALI: Is Its Use Increasing Or Decreasing: Tips In Its Use To Make It Safer By Coupling It With Mechanical Thrombectomy Devices
  Presenter(s):Marcus Thieme, MD  
  View Slides in PDF      
5:41 PM - 5:46 PM Mechanical Endothrombectomy Is Eliminating The Need For Lytic Agents And Making The Treatment Of ALI Safer
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
5:47 PM - 5:52 PM DEBATE: All Patients With ALI Can And Should Be Treated Endovascularly
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
5:53 PM - 5:58 PM DEBATE: Not So: Some Patients With ALI Require Open Treatment: Which Ones And Why: Technical Tips
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
5:59 PM - 6:04 PM New Findings In The Treatment Of ALI: From The Recently Updated European Guidelines: Paradigms Are Changing
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
6:05 PM - 6:10 PM Aspiration Thrombectomy For ALI Due To Thrombosed Popliteal Aneurysms: A Better Way To Treat: Technical Tips And Results
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
6:11 PM - 6:20 PM Panel Discussion
End of Program D

END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, ANTI-ATHEROGENIC DRUGS AND CARDIAC AND CORONARY ARTERY RISK EVALUATION IN PATIENTS WITH VASCULAR DISEASE
x
6:40 AM - 6:45 AM What Is Currently The Best Way To Assess Cardiac Risk In Open Vascular Surgery Patients; In Endovascular Treatment Patients
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
6:46 AM - 6:51 AM Fractional Flow Reserve From Coronary CT (FFRCT): What Is It, And It Is A Better Way To Guide Coronary Artery Revascularization
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM Value Of Non-Invasive FFRCT In Decreasing Cardiac Complications In Patients Undergoing Lower Extremity Revascularization (Bypasses) And CEAs: It Allows High Risk Asymptomatic Patients To Be Detected Proactively And Treat Better
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM Improvements In And What Is Coming In Medical Treatment To Prevent Death And Complications From Arteriosclerosis: Update On PCSK-9 Inhibitors Including Inclisiran, Ezetembe, Anti-Inflammatory Drugs And Treating High Lp(a) Levels
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
7:04 AM - 7:09 AM DEBATE: Adherence To Statin Therapy With Attention To Increase Dosage Of High Potency Statins (Atorvastatin And Ruvostatin) Boosts Survival And Is Valuable In The Elderly (> 75): Adverse Effects Are Rare
  Presenter(s):Richard Bulbulia, MA MD FRCS  
  View Slides in PDF      
7:10 AM - 7:15 AM DEBATE: Statins Are Not A Miracle Drug And Have Been Overvalued: They Have Unrecognized Harmful Effects As Does Excessive Lowering Of LDL Cholesterol (LDL-C): Have We Been Misled And By Whom
  Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC  
  View Slides in PDF      
7:16 AM - 7:21 AM Highlights Of The New AHA Guidelines For Management Of Cholesterol Levels: What LDL-C Levels Should We Strive For In Our Vascular Patients: Why Are Non-HDL Levels A Better Indicator Of Atherosclerotic Risk Than LDL-C Levels
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
7:22 AM - 7:27 AM Value Of Lipid Lowering For Treating Plaques In Coronary And Other Arteries: Best Drug Combination And Benefit Of PCSK-9 Inhibitors: How Low Should LDL-C Be Driven: Can Plaques Be Made Smaller And Less Dangerous
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM Current Value Of Antithrombotic And Antiplatelet Therapy In Vascular Patients: What Drugs Should They Be On – When And Why: The COMPASS RCT Shows That Low Dose Rivaroxaban And Aspirin Decreases Death, Stroke And MI In Vascular Patients: What About Aspirin Alone
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
7:34 AM - 7:39 AM How To Detect Vulnerable Plaque (Lipid Rich Plaque [LRP]) And Mortality Risk With New Infrared Spectroscopy (NIRS); How Does It Work: What Can Be Done About LRPs
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
7:40 AM - 7:47 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: MORE ADVANCES IN MEDICAL TREATMENTS; MORE ABOUT NEW DRUGS; STEM CELL TREATMENTS; CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION
x
MORE ABOUT NEW DRUG TREATMENTS
7:47 AM - 7:52 AM New RCT Evidence Shows That An Omega 3 Fatty Acid Formula, Vascepa, Reduces By 25% Major Adverse Cardiac Events In Patients With High Triglycerides (The REDUCE-IT Trial): Bempedoic Acid Reduces LDL-C And C-Reactive Protein: Improved Best Medical Treatment Will Sharply Decrease The Need For Interventional Treatments
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
7:53 AM - 7:58 AM Optimal Use Of Direct Oral Anticoagulants (DOACs) After Open Bypasses And After Endovascular Procedures
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
7:59 AM - 8:04 AM All Vascular Patients Should Be On Statins: What Drug, What Dose: It Matters: There Are Dire Penalties If Statins Are Stopped
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
UPDATE ON STEM CELL THERAPY
8:05 AM - 8:10 AM Does Stem Cell Therapy Have A Future In The Treatment Of Ischemic Vascular Disease
  Presenter(s):Dong-ik Kim, MD  
  View Slides in PDF      
8:11 AM - 8:16 AM Update On The Value Of Autologous Stem Cell Therapy To Treat Lower Extremity Ischemia: Many Studies Indicate It Helps, But Not Much
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
ADVANCES IN CATHETER BASED TREATMENT OF RESISTANT HYPERTENSION
8:17 AM - 8:22 AM Current Status And Future Potential Of Endovascular Devices In The Treatment Of Resistant Hypertension: Does Renal Denervation Work
  Presenter(s):Sahil A. Parikh, MD  
  View Slides in PDF      
8:23 AM - 8:28 AM Status Of RCTs And Other Trials Showing The Comparative Value Of Different Catheter Based Techniques For Renal Denervation For Alleviating Resistant Hypertension: Radiofrequency (Spyral – Medtronic), Ultrasound Paradise Catheter (ReCor Medical), And Alcohol Infusion Into Renal Artery Adventitia (Peregrine Catheter, Ablative Solutions); They All Work
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
8:29 AM - 8:34 AM Value Of A Stent-Like Mobius HD Device (From Vascular Dynamics) To Reshape The Carotid Sinus, Amplify The Baroreflex And Lower Blood Pressure In Drug Resistant Hypertension
  Presenter(s):Gregg W. Stone, MD / Kim J. Hodgson, MD  
  View Slides in PDF      
8:35 AM - 8:40 AM Update On Value Of ROX Coupler Device To Create An Iliac A-V Fistula And Control Blood Pressure In Resistant Hypertension: How It Works And Results Of A Sham Controlled RCT
  Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
8:41 AM - 8:46 AM Late Breaking Results Cast Doubt On The Katsanos Meta-Analysis: A Multicenter Study In 2071 Propensity Matched Patients (With CTLI And IC) Shows No Mortality Effect Of Paclitaxel Coated Devices 2 Years After Treatment
  Presenter(s):Hany Zayed, MD  
  View Slides in PDF      
8:47 AM - 8:54 AM Panel Discussion
8:54 AM - 9:04 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN MANAGING COMPLICATIONS AND ENDOLEAKS AFTER EVAR AND TEVAR
x
9:04 AM - 9:09 AM Total Aortic Occlusion With Worsening Visceral And Renal Ischemia After TEVAR For Acute TBAD Can Be Due To Complete Dissection Flap Detachment And Distal Migration: Causes And Diagnosis: Urgent Open Flap Excision Is Life-Saving
  Presenter(s):Mark K. Eskandari, MD / Heron E. Rodriguez, MD  
  View Slides in PDF      
9:10 AM - 9:15 AM Major Trauma Can Lead To High Flow Endoleaks In EVAR Patients: What Is The Mechanism: What Is The Best Treatment
  Presenter(s):Carlo Setacci, MD  
  View Slides in PDF      
9:16 AM - 9:21 AM Endoleaks After TEVAR: Incidence, Nature, Etiology, Diagnosis And Treatment
  Presenter(s):Maciej L. Dryjski, MD, PhD  
  View Slides in PDF      
9:22 AM - 9:27 AM Natural History Of Type 2 Endoleaks With And Without Treatment: From A 1000 Patient Study
  Presenter(s):Carlo Pratesi, MD / Raffaele Pulli, MD  
  View Slides in PDF      
9:28 AM - 9:33 AM Little Known Facts About Endoleaks After EVAR: Natural History Of Late Type 1 Endoleaks Is Not Benign – Urgent Treatment Is Required: An Enlarging AAA Sac With A Type 2 Endoleak Usually Indicates The Presence Of An Associated Type 1 Endoleak
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
9:34 AM - 9:39 AM Value Of CT Fusion Guidance And Liquid Embolic Agents To Treat Type 2 Endoleaks: Technical Tips And How To Do It With The Best Chance Of Success
  Presenter(s):Neal S. Cayne, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM How Common Are Failures Of Interventions For Type 2 Endoleaks: What Are The Reasons And When Is Open Treatment Indicated: What Should That Open Treatment Be
  Presenter(s):Ronald M. Fairman, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM Minimizing Type 2 Endoleaks With Careful Imaging And Pre-EVAR Side Branch Coiling: It Works: Technical Tips
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
9:52 AM - 9:59 AM Panel Discussion
9:59 AM - 10:04 AM Transgraft Access And Onyx Embolization For Type 2 Endoleaks Difficult To Approach And Treat: Technique And Results
  Presenter(s):Mark W. Mewissen, MD, RVT  
  View Slides in PDF      
10:05 AM - 10:10 AM Optimal Strategy For And Results Of Treating Type 2 Endoleaks: It Is Not Simple
  Presenter(s):Sonia Ronchey, MD, PhD  
  View Slides in PDF      
10:11 AM - 10:16 AM Role Of Anticoagulation And Endogenous Thrombolysis In The Occurrence And Resolution Of Late Type 2 Endoleaks: How Should They Influence Treatment
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
10:17 AM - 10:22 AM Value Of Fibrin Glue Sac Filling With EVAR To Prevent Type 2 Endoleaks: Technique, Value And Limitations
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
10:23 AM - 10:28 AM Sac Access Routes To Treat Type 2 Endoleaks: Techniques, Advantages And Limitations Of Each
  Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM Treating Type 2 Endoleaks By A Paragraft Approach: Indications, Technique And Results
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
10:35 AM - 10:40 AM How Does Endograft Covering Material (Polyester vs. PTFE) Influence Type 2 Endoleak Rates And Behavior After EVAR
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM Value Of Liquid Embolic Agents And Onyx In Treating Type 1 And Type 2 Endoleaks: Technical Tips And Results
  Presenter(s):Robert A. Morgan, MD  
  View Slides in PDF      
10:47 AM - 10:52 AM Importance Of Recognizing Visceral Artery Occlusive Disease Before Performing EVAR: How To Diagnose And Treat
  Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD  
  View Slides in PDF      
10:53 AM - 11:00 AM Panel Discussion
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: RECORDED LIVE CHALLENGING AND COMPLEX CASES FROM LINC AND LEIPZIG
x
11:00 AM - 11:20 AM Vessel Preparation By Mechanical Debulking Using The Rotarex Atherectomy System; Including Recorded Case Presentation
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
11:20 AM - 11:40 AM Minimally Invasive Solutions For Challenging Peripheral Occlusions: The PQ-Bypass Technique; Including Recorded Case Presentation
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
11:40 AM - 11:50 PM Optimizing Results Of BTK Procedures: Latest Data On BTK DCB From The AcoARt BTK Study And Optimization Of Recanalization Results With Tack BTK Scaffolds; Including Recorded Case Presentation
  Presenter(s):Dierk Scheinert, MD  
  View Slides in PDF      
11:50 AM - 12:00 PM DCB And Tack Treatment Of BTK CTOs
  Presenter(s):Andrej Schmidt, MD  
12:00 PM - 12:50 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
x
12:50 PM - 12:57 PM When Is A Technically Successful Arterialization Of The Foot Veins Effective In Preventing Amputation In No-Option CLI Patients
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
12:57 PM - 12:59 PM Discussion
12:59 PM - 1:06 PM Open Surgery For Infra- And Juxtrarenal AAA In The Endovascular Era
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
1:06 PM - 1:08 PM Discussion
1:08 PM - 1:15 PM Unexpected Initial And Final Completion Angiogram For A First In Human Fenestrated Endograf
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
1:15 PM - 1:17 PM Discussion
1:17 PM - 1:24 PM Single Session Venous Thrombectomy For Acute Ilio-Femoral Deep Vein Thrombosis: The Advantages Of ZERO Thrombolysis
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Slides in PDF      
1:24 PM - 1:26 PM Discussion
1:26 PM - 1:33 PM Most Successful Tools For Complex Femoropopliteal CTO Recanalizations
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
1:33 PM - 1:35 PM Discussion
1:35 PM - 1:42 PM Endovascular Management Of Complex Fem-Pop And Below Lesions In 2019
  Presenter(s):Lorenzo Patrone, MD / Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
1:42 PM - 1:44 PM Discussion
1:44 PM - 1:51 PM Vessel Preparation – Is It Relevant In The Tibial Arteries
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
1:51 PM - 1:53 PM Discussion
1:53 PM - 1:59 PM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: TRIBUTE TO A VALUED PARTNER; IMPORTANT ISSUES RELATED TO VASCULAR PRACTICE AND VASCULAR SURGEONS
x
2:00 PM - 2:05 PM A Tribute To Sushil K. Gupta, MD, MBA (1949-2019) – A Creative And Talented Surgeon, A Brilliant Innovator And A Treasured Colleague And Friend
  Presenter(s):Larry A. Scher, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM Trials And RCTs Versus Registries: Advantages And Disadvantages Of Each: How Can We Reach The Truth
  Presenter(s):Charles C. Miller, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Keys To A Successful Career In Vascular Surgery
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM How Vascular Surgeons Can Develop Leadership Skills
  Presenter(s):Robert B. McLafferty, MD, MBA  
  View Slides in PDF      
2:24 PM - 2:29 PM How Women Vascular Surgeons Look Differently At Gender Differences In Procedural Results Than Their Male Counterparts And Why This Is Advantageous For Female Patients
  Presenter(s):Rebeca Reachi Lugo, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM How To Teach Competent Open Surgery In The Endovascular Era
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Vascular Surgery Burnout: Why It Occurs: Is It Related To Occupational Or Ergonomic Ailments And Pain: What Can Be Done To Prevent And Fix The Problem
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
2:42 PM - 2:47 PM What Constitutes Futility In Our Present Health Care System: When Is Enough Too Much
  Presenter(s):James W. Jones, MD, PhD, MHA  
  View Slides in PDF      
2:48 PM - 2:53 PM Panel Discussion
2:53 PM - 2:58 PM Lessons Learned By A Creative Physician-Inventor: How To Avoid The Pitfalls In Bringing An Idea To Fruition Without Losing Your Idea Or Your Shirt
  Presenter(s):Lindsay Machan, MD  
  View Slides in PDF      
2:59 PM - 3:04 PM How Are Silicon Valley Giants And Entrepreneurs Planning To Disrupt Health Care: Will It Improve Things For Patients; For Doctors; For Vascular Specialists
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
3:05 PM - 3:10 PM Screening For Vascular Diseases Can Cause More Harm Than Benefit: How To Avoid This Problem
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
3:11 PM - 3:16 PM Variations Around The World In The Treatment Of AAAs And Carotid Stenosis Patients: What Are The Implications: From The Consortium Of Vascular Registries
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
3:17 PM - 3:22 PM Are There Problems With The Appropriateness Of Invasive Treatment By Vascular Surgeons, By Other Vascular Specialists
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
3:23 PM - 3:28 PM The Hospital Readmission Reduction Program And Its Incentives Have Led To Increased Morbidity And Mortality For Vascular Patients: How Can It Be Fixed To Make It Safe
  Presenter(s):Philip P. Goodney, MD, MS / Janet T. Powell, MD, PhD  
  View Slides in PDF      
3:29 PM - 3:34 PM What Is The Impact Of The New AAA DRGs On Hospital Reimbursement: Does More Have To Be Done
  Presenter(s):W. Charles Sternbergh III, MD  
  View Slides in PDF      
3:35 PM - 3:40 PM Panel Discussion
3:40 PM - 3:48 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: ISSUES RELATED TO VASCULAR OUTPATIENT CENTERS, OFFICE BASED LABS AND MEDICAL ETHICS
x
3:48 PM - 3:53 PM Why Outpatient Centers And Office Based Labs (OBLs) Are The Best Place To Do Which Endovascular Procedures: Best For Patients And Best For Operators: When Can Atherectomies Be Performed Safely There; When Not
  Presenter(s):Krishna Jain, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM Real World Results Of Lower Extremity Atherectomy (Mostly In Outpatient Centers) From Medicare Billing Data Is Much Worse Than Favorable Registry Data: Where Lies The Truth
  Presenter(s):Dipankar Mukherjee, MD  
  View Slides in PDF      
4:00 PM - 4:05 PM How To Avoid Unethical Practices In An Outpatient Center Or Office Based Lab (OBL): The Temptation And Incentives To Overtreat Is Great
  Presenter(s):Stephen M. Bauer, MD  
  View Slides in PDF      
4:06 PM - 4:11 PM Characteristics Of Physicians Who Are Suited To Work In An OBL And Characteristics Of Those Who Are Not
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
  View Slides in PDF      
4:12 PM - 4:17 PM Office Based Versus Hospital Based Vascular Care: Impact On Indications, Physician Income And Overall Costs
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
  View Slides in PDF      
4:18 PM - 4:23 PM Another View Of The Impact Of Office Based Vascular Practice Patterns On Indications, Physician Incomes And Outcomes
  Presenter(s):Matthew W. Mell, MD, MS  
  View Slides in PDF      
4:24 PM - 4:29 PM A Propensity Matched Comparison Of Paclitaxel Coated DCBs Versus POBA In Patients With Intermittent Claudication: 5-Year Results Show No Increased Mortality Signal For DCBs
  Presenter(s):Georgios A. Pitoulias, MD, PhD / Konstantinos P. Donas, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Vascular Screening Is Often Unnecessary, Possibly Harmful And Largely Driven By Financial Gain: When Is It Justified And Beneficial To Patients
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
4:36 PM - 4:41 PM Advantages To A Vascular Practice Of Having A Wound Care Center
  Presenter(s):Venita Chandra, MD  
  View Slides in PDF      
4:42 PM - 4:47 PM Benefits To A Vascular Practice And Hospital Of Having A Limb Salvage Program: How To Set One Up And Make It Work
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS  
  View Slides in PDF      
4:48 PM - 4:55 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: TOPICS RELATED TO THE FDA, VALUE OF A VASCULAR SURGEON, VASCULAR PRACTICE, THE SVS, VQI AND GOVERNMENTAL REGULATIONS AND REIMBURSEMENT
x
4:55 PM - 5:00 PM How Innovative Vascular Devices Can Get To Market: What Is The De Novo Pathway
  Presenter(s):Dorothy B. Abel, BSBME  
  View Slides in PDF      
5:01 PM - 5:06 PM What Is The Value Of A Vascular Surgeon To A Health Care System In And Out Of The Operating Room: In Many Ways It Is Priceless But Under-Rewarded
  Presenter(s):Richard J. Powell, MD / Fred A. Weaver, MD, MMM  
  View Slides in PDF      
5:07 PM - 5:12 PM How Can Vascular Surgeons Best Cope In A MIPS And MACRA World: What Will Happen With The Medical Device Excise Tax In 2020 And Why Its Repeal Is Important To Vascular Surgeons And Vascular Specialists
  Presenter(s):Robert M. Zwolak, MD, PhD  
  View Slides in PDF      
5:13 PM - 5:18 PM What Is On The Horizon For Vascular Surgeons And Vascular Specialists Reimbursement: Will Income Go Up Or Down For The Same Amount Of Work
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
5:19 PM - 5:24 PM Opposite Trends In Reimbursement By CMS For Arterial And Venous Procedures: Implications For Vascular Surgery Practices
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
5:25 PM - 5:30 PM Revascularization For CLTI By Endovascular Treatments Or Open Surgery Is Cost Effective And Saves Lives Compared To Major Amputations
  Presenter(s):Richard F. Neville, MD / Jihad A. Mustapha, MD  
  View Slides in PDF      
5:31 PM - 5:36 PM How To Shorten Lengths Of Stay After Vascular Open Surgery Or Interventions: It Is Not Easy, But It Is Doable
  Presenter(s):Fred A. Weaver, MD, MMM  
  View Slides in PDF      
5:37 PM - 5:42 PM Progress In And Value Of The SVS VQI Program: Where Is It Going And Why Will It Become Increasingly Important
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
5:43 PM - 5:48 PM Improvements In Vascular Specialist, The SVS Newspaper: Opportunities And Challenges And How It Can Benefit Vascular Surgeons And Others
  Presenter(s):Malachi Sheahan, MD  
  View Slides in PDF      
5:49 PM - 5:54 PM Recent Improvements In The JVS: How To Get A Paper Accepted In The JVS: How Best To Review A Paper For The JVS
  Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD  
  View Slides in PDF      
5:55 PM - 6:02 PM Panel Discussion
End of Program E

END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE TOPICS RELATED TO NEW DEVELOPMENTS IN TREATING AORTIC DISSECTIONS AND ITS COMPLICATIONS
x
6:40 AM - 6:45 AM Retrograde SMA Stenting May Be The Best Way To Treat Mesenteric Compromise From Malperfusion With Aortic Dissections: How To Do It And Results
  Presenter(s):Dipankar Mukherjee, MD  
  View Slides in PDF      
6:46 AM - 6:51 AM When Can The Celiac Trunk Orifice Be Covered Safely During TEVAR And When Not: From A New Meta-Analysis
  Presenter(s):Wayne W. Zhang, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM Left Subclavian Revascularization During Zone 2 TEVARs: Comparison Of Open Surgical Bypass Versus Endovascular Revascularization With Parallel Grafts (Chimney Or Periscope)
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM When Should False Lumen Thrombosing Techniques Be Used In Patients With TBADs: How Best To Do It
  Presenter(s):Thomas L. Forbes, MD / Cherrie Z. Abraham, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM New Technique For False Lumen Occlusion In Chronic Aortic Dissections: Using A Physician Modified Device: How To Do It And Results
  Presenter(s):I-Hui Wu, MD, PhD  
  View Slides in PDF      
7:10 AM - 7:15 AM New Proximal And Distal Re-Entry Tears After TEVAR: What Are The Causative Mechanisms, Risk Factors And Treatments
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
7:16 AM - 7:21 AM Another View On Endograft Induced Distal Re-Entry Tears After TEVAR: Strategies To Prevent, Diagnose And Treat
  Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD  
  View Slides in PDF      
7:22 AM - 7:27 AM Best Treatment Options For Aortic Dissections In Patients With Connective Tissue Disorders: When Endo; When Open; When Hybrid
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM EVAR And TEVAR Can Work Surprisingly Well In Some Aneurysm Patients With Connective Tissue Disorders; When And When Not: Technical Tips
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
7:34 AM - 7:39 AM With TBADs, What Are The Flow/Pressure Dynamics That Explain Why TEVAR Can Make Things Worse
  Presenter(s):Firas F. Mussa, MD  
  View Slides in PDF      
7:40 AM - 7:45 AM Advantages To Hybrid Approaches To Complex Aortic And Aortovisceral Artery Pathology: Indications And Technical Tips
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Slides in PDF      
7:46 AM - 7:54 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE NEW DEVELOPMENTS RELATED TO THE ASCENDING AORTA, AORTIC ARCH, F/B/TEVAR AND PARALLEL GRAFTS FOR TREATMENT OF LESIONS IN OR NEAR THE AORTIC ARCH
x
7:54 AM - 7:59 AM Wrapping Of The Dilated Ascending Aorta To Avoid More Complex Procedures And Facilitate Placement Of Grafts To Arch Branches: Indications, Contraindications, Technical Tips And Results
  Presenter(s):Mario L. Lachat, MD / Ralf R. Kolvenbach, MD  
  View Slides in PDF      
8:00 AM - 8:05 AM Variations In The Morphology Of Proximal Entry Tears In TBADs: Importance Of These Variations And How Should They Influence Treatment
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
8:06 AM - 8:11 AM Significance Of Aortic Arch Anomalies: What Are They Associated With: When Do They Require Treatment: What Is The Best Current Treatment
  Presenter(s):Erik E. Debing, MD, PhD  
  View Slides in PDF      
8:12 AM - 8:17 AM What Do Fluid Dynamics Tell Us About The Durability And Long-Term Results Of Aortic Arch Branch And Fenestrated Endografts
  Presenter(s):Santi Trimarchi, MD, PhD  
  View Slides in PDF      
8:18 AM - 8:23 AM 3-Branch Endograft For Aortic Arch Aneurysm Repair (From Terumo Aortic): Advantages, Limitations And Results To Date
  Presenter(s):W. Anthony Lee, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM Unusual Branched Endograft Solutions For Aortic Arch Lesions When Industry-Made Commercial Devices Are Unavailable Or Unsuitable
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
  View Slides in PDF      
8:30 AM - 8:35 AM How Best To Treat TBADs Extending Into The Arch And Ascending Aorta
  Presenter(s):I-Hui Wu, MD, PhD  
  View Slides in PDF      
8:36 AM - 8:41 AM Value Of Chimney TEVAR (Ch/TEVAR) To Treat Elective And Ruptured Aneurysms Involving The Aortic Arch: A 15-Year Experience And Results
  Presenter(s):Thomas Larzon, MD, PhD / Tal M. Hörer, MD, PhD  
  View Slides in PDF      
8:42 AM - 8:47 AM Ch/TEVAR In The Aortic Arch If Done Right Is As Good As F/B/TEVAR And Safer Than Open Surgery: Technical Tips And Results
  Presenter(s):Armando C. Lobato, MD, PhD / Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
8:48 AM - 8:53 AM Update On Sandwich Grafts For Zone 0 Aortic Arch Lesions: 8-Year Results And Technical Tips
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
8:54 AM - 9:02 AM Panel Discussion
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: MORE ABOUT JUXTA- AND PARARENAL AAAs, TAAAs, F/B/EVAR AND PARALLEL GRAFTS (CHIMNEY EVAR [Ch/EVAR])
x
9:02 AM - 9:07 AM A New And Better Way To Define And Classify AAA Neck Anatomy And Indicate Best Treatment
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
9:08 AM - 9:13 AM For Juxta- And Pararenal AAAs Ch/EVAR Can Yield Dependably Good And Durable Results If Certain Technical Requirements Are Followed And Certain Device Combinations Are Used: Results From The ENCHANT Registry
  Presenter(s):Giovanni Torsello, MD / Konstantinos P. Donas, MD  
  View Slides in PDF      
9:14 AM - 9:19 AM Ch/EVAR For Juxta And Pararenal AAA: Technical Tips To Assure Good Long-Term Results: A 9-Year Experience
  Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD  
  View Slides in PDF      
9:20 AM - 9:25 AM Indications For Chimney And Sandwich Grafts In The F/B/EVAR Era: Yes They Exist
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
9:26 AM - 9:31 AM Repair Of Juxta- And Pararenal AAAs Using A Combination Of Fenestrations And Chimney Grafts: Advantages, Techniques And Results
  Presenter(s):Mark W. Mewissen, MD, RVT  
  View Slides in PDF      
9:32 AM - 9:37 AM How To Rescue A F/EVAR Procedure When The Fenestrations Are Poorly Aligned With Branch Orifices: Why Does It Happen
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
9:38 AM - 9:43 AM Main Graft Body Alignment With Branch Orifices Is Not An Issue With Parallel Grafts (Ch/EVAR) And How Do Variable Curvature Sheaths Help With Both F/EVAR And Ch/EVAR
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
9:44 AM - 9:49 AM DEBATE: Long-Term Results Of F/B/EVAR For Pararenal AAAs Show That It Should Be The Procedure Of Choice And TAAAs In Anatomically Suited Patients Which Is Most Of The Time
  Presenter(s):Piergiorgio Cao, MD, FRCS  
  View Slides in PDF      
9:50 AM - 9:55 AM DEBATE: Not So: Open Repair Still Has A Major Role For Treating Many Patients With Pararenal AAAs And TAAAs
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
9:56 AM - 10:01 AM United Kingdom Assessment Of Countrywide Outcomes And Cost For Treating Complex AAAs: Is Endo Equal To Or Better Than Open Repair In Any Way
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
10:02 AM - 10:10 AM Panel Discussion
10:10 AM - 10:20 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS; NEW DEVELOPMENTS IN TREATING ILIAC ANEURYSMS AND REVASCULARIZING HYPOGASTRIC ARTERIES
x
UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS
10:20 AM - 10:25 AM Multilayer Flow Modulating (MLFM) Uncovered Stents (From Cardiatis): Indications, Contraindications, Advantages And Results
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
10:26 AM - 10:31 AM Why MLFM Uncovered Stents Should Be The First Choice For Treating Renal, Visceral And Popliteal Aneurysms And Possibly Other Lesions: Results Show That These Stents Preserve Branch Flow And Prevent Aneurysm Rupture
  Presenter(s):Michel C. Henry, MD  
  View Slides in PDF      
10:32 AM - 10:37 AM Role Of MLFM Uncovered Stents To Treat Type A Aortic Dissections: Indications, Advantages, Limitations And Results
  Presenter(s):Victor S. Costache, MD, PhD  
  View Slides in PDF      
10:38 AM - 10:43 AM Value Of MLFM Uncovered Stents To Treat Aortic Dissections And Recurrent Emboli From Paroxysmal Atrial Fibrillation: They Prevent Emboli From Going To The Brain
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
10:44 AM - 10:49 AM Role Of MLFM Stents For Treating Type A And B Aortic Dissections: Indications And Results: What About For Complex Aneurysm Treatment
  Presenter(s):Zoran Stankov, MD / Ivo Petrov, MD, PhD  
  View Slides in PDF      
10:50 AM - 10:55 AM MLFM Uncovered Stents For Treating Complex AAAs And TAAAs: What Do The Longer-Term Results From The Multicenter DRAGON Trial Show: Do These Stents Prevent Rupture
  Presenter(s):Claude D. Vaislic, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM Long-Term Follow-Up Of Multilayer Bare Stent Treatment Of TAAAs, Complex AAAs And Type B Aortic Dissections: The Moroccan Experience
  Presenter(s):Amira Benjelloun, MD  
  View Slides in PDF      
11:02 AM - 11:07 AM Panel Discussion
TREATMENT OF ILIAC ANEURYSM AND PRESERVING HYPOGASTRIC FLOW
11:07 AM - 11:12 AM Comparing The Various Industry-Made Iliac Branch Devices (IBDs) For Treating Common And Internal Iliac Aneurysms: Advantages And Limitations Of Each: When To Use Which One
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
11:13 AM - 11:18 AM Advantages, Limitations And Results Of Unilateral And Bilateral Gore IBD To Treat AAAs With Iliac Aneurysms: Early Results From The International ICEBERG Registry
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Thomas S. Maldonado, MD  
  View Slides in PDF      
11:19 AM - 11:24 AM How To Prevent Complications And Failure With The Gore IBD When The Anatomy Is Tortuous: What Is The Iliac Tortuosity Index And How Does It Help
  Presenter(s):Jon S. Matsumura, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM Value Of IBDs To Treat Isolated (No AAA) Common And Internal Iliac Aneurysms: At What Size Should They Be Treated: Which Device Is Best
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
11:31 AM - 11:36 AM Advantages And Limitations Of The Jotec-Cryolife IBD For Treating Common And Internal Iliac Aneurysms; This Device Works Well With The Endurant Endograft (Medtronic)
  Presenter(s):Lee Bouwman, MD, PhD, MSc  
  View Slides in PDF      
11:37 AM - 11:42 AM When The Anatomy Is Not Suitable For An IBD, How Can Hypogastric Flow Be Preserved: Sandwich Grafts, External Iliac-To-Hypogastric Grafts Open Or Endo With An Aorto-Uni-Iliac EVAR, Etc.
  Presenter(s):Martin R. Back, MD  
  View Slides in PDF      
11:43 AM - 11:48 AM How Common Iliac Aneurysms (CIAs) Have An Impact On Aortic Morphology: Why A New Classification System For CIAs Will Be Helpful
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
11:49 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: INTERESTING NEW DEVELOPMENTS IN STANDARD EVAR AND INFRARENAL AAAs: ACCEPTABLE NECK ANATOMY; NEW GUIDELINES; AAA SAC THROMBUS AND SHRINKAGE; NEW CLASSIFICATION SYSTEM; EFFECT OF STEROIDS ON EVAR
x
1:00 PM - 1:05 PM AAA Sac Shrinkage Is A Good Marker Of Durable Success After EVAR: Which Endografts Have The Best Rates Of Sac Shrinkage
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Large Diameter Of The Flow Lumen In AAAs Is A Risk Factor For A Poor Outcome After EVAR Just Like Large Proximal Neck Diameter: What Are The Reasons For These Observations
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Large Proximal Necks (> 28 mm In Diameter) Are Predictive Of A Poor Outcome From EVAR: Based On A Meta-Analysis
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Highlights From The New 2019 European (ESVS) AAA Guidelines: What Is Different And Better About Them
  Presenter(s):Sebastian E. Debus, MD, PhD / Anders Wanhainen, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM Comparison Of The US (SVS) And ESVS AAA Guidelines: Why Are The US Guidelines Better
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Increasing Disparity Between The SVS Guideline AAA Indications For AAA Repair And Real World Practice: Are The Guidelines Relevant Currently
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
1:36 PM - 1:41 PM DEBATE: Increasing Volume Of Mural Clot Within An AAA Sac Does Not Increase The Rupture Risk
  Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS  
  View Slides in PDF      
1:42 PM - 1:47 PM DEBATE: Not So: Increasing Thrombus Volume Within An AAA Sac Correlates With Increasing Risk Of Complications And Rupture: What Is The Mechanism
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
1:48 PM - 1:53 PM A New Classification System For AAAs Helps In Understanding Their Behavior, In Determining Treatments And Evaluating Them
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Does Preprocedure Steroid Administration Before EVAR Produce A More Benign Postprocedure Course And Facilitate Earlier Discharge: What Is The Mechanism
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: MORE NEW DEVELOPMENTS IN AAA PATHOGENESIS, NATURAL HISTORY AND TREATMENT
x
2:06 PM - 2:11 PM Inflammatory AAAs: Medical Treatment With Steroids Is Adequate For Many Patients With Them: What Is The Regimen And Results: When Is Invasive Treatment Needed – Open Or Endo
  Presenter(s):Julien G. Sfeir, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM How Long Can Patients With Moderate Sized AAAs Safely Wait For Elective Repair: Rupture Risk For AAAs < 6.0 cm In Diameter Is Low And Overemphasized
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
2:18 PM - 2:23 PM Acceptable Results Can Be Achieved With EVAR Devices Used Outside IFU Requirements If Certain Precautions Are Followed: What Are They And What Are The Limitations
  Presenter(s):Francesco Speziale, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Depleted Nutritional Status And Muscle Mass Increases The Risk Of Open AAA Repair: What About With EVAR
  Presenter(s):Kimihiro Komori, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM Why F/EVAR For Failed EVAR Is Not Simple: Technical Tips To Make It Work
  Presenter(s):Barend M.E. Mees, MD, PhD  
  View Slides in PDF      
2:36 PM - 2:41 PM A New Gene Family That May Be Vital In Causing AAAs: The Gene Can Be Identified From Skin Biopsies: How Can They Help In Diagnosis And Treatment
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
2:42 PM - 2:47 PM Comparison Of Aortic Neck Dilatation After AAA Repair In Patients Undergoing EVAR Versus Open Repair: From The DREAM Trial Which Allows This Comparison To Be Made In Patients Suitable For Both Procedures
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM How Should AAA Shape (With An Eccentric Sac Or Two Sacs) Influence Indications For Repair: How Should Diameter Measurements Be Made In These Circumstances
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
2:54 PM - 3:00 PM Increasing Requirement For Open Conversion Following EVAR: Reasons For And Technical Tips: Why Is It More Often Required For A Persistent Type 2 Endoleak With An Enlarging AAA Sac
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
3:00 PM - 3:15 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASES AND THEIR TREATMENT (4 ¾- MINUTE FAST PACED TALKS)
x
EVAR AND AAA RELATED TOPICS
3:15 PM - 3:20 PM External Iliac To Internal Iliac Artery Bypass: Does It Have A Role In Preserving Hypogastric Flow In The Endo Era: Technical Tips
  Presenter(s):Heron E. Rodriguez, MD  
  View Slides in PDF      
3:20 PM - 3:25 PM Value And Indications For Preprocedural Embolization Of The IMA And Lumbar Arteries Before EVAR
  Presenter(s):Timothy M. Sullivan, MD / Jesse Manunga, MD  
  View Slides in PDF      
3:25 PM - 3:30 PM Increasing Role Of Endovascular Treatments And EVAR For Vascular Complications Of Connective Tissue Disorders
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
3:30 PM - 3:35 PM Why Should Aortic AAA Neck Dilatation Differ After EVAR And After F/EVAR: Does It
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
3:35 PM - 3:40 PM EVAR Treatment Of Atypical AAAs: Technical Tips And Special Precautions
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
3:40 PM - 3:45 PM 5 Years After AAA Repair The Quality Of Life Is Better In Those Having EVAR Than In Those Having Open Repair
  Presenter(s):Mauro Gargiulo, MD / Gianluca Faggioli, MD  
  View Slides in PDF      
3:45 PM - 3:50 PM Why Do Fluoroquin Drugs Increase The Risk Of Aortic Aneurysms And Dissections
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
3:50 PM - 3:55 PM Panel Discussion
F/B/EVAR AND PARALLEL GRAFT RELATED TOPICS
3:55 PM - 4:00 PM When With F/EVAR Should A Renal Or Mesenteric Branch Not Be Stented
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
4:00 PM - 4:05 PM Avoid Complications And Problems From Parallel Grafts And How To Make Them Work Safely And Effectively
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
4:05 PM - 4:10 PM Update On In Situ Fenestration For Branch Revascularization: How To Use It For Renal And Mesenteric Branches In Urgent TAAA Repairs: Imaging Is Key And It Is Not Simple
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:10 PM - 4:15 PM Multicenter Results Of The t-Branch Off-The-Shelf Graft (From Cook) For TAAA Repairs: Advantages, Technical Tips, Limitations
  Presenter(s):Martin J. Austermann, MD  
  View Slides in PDF      
AORTIC DISSECTION RELATED TOPICS
4:15 PM - 4:20 PM The SKIRT Stent-Graft To Prevent Endoleaks From Fenestrated And Chimney TEVARs: How Does It Work
  Presenter(s):Chang Shu, MD  
  View Slides in PDF      
4:20 PM - 4:25 PM Troubleshooting Challenging TBADs During Endovascular Treatment And Making TEVAR Work Safely And Effectively
  Presenter(s):Rami Tadros, MD / Michael L. Marin, MD  
  View Slides in PDF      
4:25 PM - 4:30 PM Branched Endografts For Treating Aortic Dissections: Which Graft For Which Patient And Anatomy: Technical Tips
  Presenter(s):Luis A. Sanchez, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTIC AND CAROTID DISEASES AND THEIR TREATMENT (4 ¾-MINUTE FAST PACED TALKS)
x
AORTA RELATED TOPICS
4:35 PM - 4:40 PM International Comparison Of How AAAs Are Treated And How It Influences Results
  Presenter(s):Pete Holt, MD, PhD  
  View Slides in PDF      
4:40 PM - 4:45 PM Long-Term Outcomes From The OVER RCT Comparing AAA Treatment With EVAR Versus Open Repair: How Are Results Similar And How Do They Differ From The EVAR 1 And DREAM RCTs And Why
  Presenter(s):Jon S. Matsumura, MD  
  View Slides in PDF      
4:45 PM - 4:50 PM At What Size Do Hypogastric Aneurysm Need To Be Treated: How Best To Do It And Technical Tips
  Presenter(s):Darren B. Schneider, MD  
  View Slides in PDF      
4:50 PM - 4:55 PM Safe F/B/EVAR In Patients With Chronic Kidney Disease: Intravascular Ultrasound (IVUS) Helps: Technical Tips
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM Acute Kidney Injury During F/B/EVAR: What Are The Long-Term Consequences And What Can Be Done To Prevent Or Treat It Better
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM Why Outcomes Of F/B/EVAR For Women Are Different Than Those For Men: What Are The Implications
  Presenter(s):Tara M. Mastracci, MD  
  View Slides in PDF      
5:05 PM - 5:10 PM Progress And Improvements In F/B/EVAR Decrease Complications And Improve Results
  Presenter(s):Federico E. Parodi, MD  
  View Slides in PDF      
5:10 PM - 5:15 PM New Developments In The Treatment And Results Of Aorto-Enteric Fistulas: From The Low Frequency Vascular Disease Consortium
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
5:15 PM - 5:20 PM Technical Tips For AAA Sac Branch Embolization During EVAR: When And How To Do It And What Is Its Value
  Presenter(s):Eric Allaire, MD, PhD  
  View Slides in PDF      
5:20 PM - 5:25 PM Panel Discussion
CAROTID RELATED TOPICS
5:25 PM - 5:30 PM Mini-Incision CEA Is Safer, Cheaper And More Effective Than TCAR: How To Do It In Most Patients Needing Invasive Treatment
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
5:30 PM - 5:35 PM Update On Current Outcomes Of CEA And CAS In Women: What Are The Implications
  Presenter(s):Caron B. Rockman, MD  
  View Slides in PDF      
5:35 PM - 5:40 PM DEBATE: Screening For Carotid Disease Will Prevent Strokes And Should Be Expanded: To Whom
  Presenter(s):George S. Lavenson, MD  
  View Slides in PDF      
5:40 PM - 5:45 PM DEBATE: Not So: Screening More Widely For Carotid Disease Will Cause More Harm Than Benefit: Why
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
5:45 PM - 5:50 PM Safety Of CEA And CAS In Patients With A History Of Coronary Artery Disease: From The 4 RCTs
  Presenter(s):Gert J. de Borst, MD, PhD  
  View Slides in PDF      
5:50 PM - 5:55 PM Technical Tips And Indications For Eversion CEA: When Is It Best And When Not
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
5:55 PM - 6:00 PM Panel Discussion
End of Program F

END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES OR DEVICES
x
6:45 AM - 6:50 AM Theoretically Promising Technologies Don’t Always Work Out: Reasons And Implications For Creative Vascular Surgeons And Specialists
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Slides in PDF      
6:51 AM - 6:56 AM Lumee Implantable 02 Sensors; How Do They Work; How Accurate Are They And How Can They Help During And After Foot Revascularization Procedures: The OMNIA Trial
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Iliac Artery Endofibrosis: External Iliac Occlusive Disease In Young Athletes (Especially Cyclists): Pathogenesis And Optimal Treatment – Endo Treatments Don’t Work
  Presenter(s):Kenneth J. Cherry, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM Progress In Transcatheter Aortic Valve Replacement (TAVR): An Interventional Cardiologist’s View
  Presenter(s):Martin B. Leon, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM Can Increased H20 Intake (> 2 liters/day) Improve Symptoms And Heal Lesions In Patients With Claudication And CLTI: What Is The Evidence: What Is The Mechanism: Will It Replace Some Invasive Therapy
  Presenter(s):Juan C. Parodi, MD  
  View Slides in PDF      
7:15 AM - 7:20 AM Restricting Needed Transfusion In Patients Undergoing Vascular Procedures Is Bad Practice: So-Called Permissive Anemia After Vascular Operations Or Procedures Increases Morbidity And Mortality
  Presenter(s):Panos Kougias, MD, MSc / Joseph L. Mills, MD  
  View Slides in PDF      
7:21 AM - 7:26 AM Advantages Of Curved Balloons (Curved When Inflated) In Endovascular Procedures: How Do They Work And When Will They Be Available
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
7:27 AM - 7:32 AM A F/EVAR Device Automatically Computer Generated From CTA Images With Compensation For Device Induced Anatomic Changes And A Specialized Stent-Graft (BoulEVARd) For FEVAR Branches
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
7:33 AM - 7:38 AM Non-Invasive Measurement Of Intra-Arterial Pressure Gradients And Vector Flow Imaging: Current Status And Value In Endovascular Treatments
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
7:39 AM - 7:44 AM A New Retrievable Stent Device (The Rescue Stent) To Control Massive Aortic And Caval Bleeding Without Fluoroscopy: How Does It Work And Experience To Date
  Presenter(s):Bryan W. Tillman, MD, PhD / Michel Makaroun, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM Update On The Art-Assist Device To Provide Pneumatic Sequential Compression For Ischemia: It Is The Best Treatment For Many CLTI Patients: How It Works And Results From A 20-Year Experience
  Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC  
  View Slides in PDF      
7:51 AM - 8:00 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: NEW DEVELOPMENTS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs)
x
8:00 AM - 8:05 AM New Findings From The UK Complex AAA Multicenter Study Comparing Outcomes And Cost For F/B/EVAR Versus Open Repair For Juxta- And Pararenal AAAs And TAAAs
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Slides in PDF      
8:06 AM - 8:11 AM Update On The Results Of The French Multicenter Study Comparing Outcomes And Costs Of F/EVAR And Open Repair For Complex AAAs
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
8:12 AM - 8:17 AM Update On Improving Results With F/B/EVAR For Complex AAAs: How Are The New Bridging Stent-Grafts And Inner Branched Grafts Helping And Making Procedures More Effective
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
  View Slides in PDF      
8:18 AM - 8:23 AM Expanded Use Of Preloaded Catheters And Wires For F/B/EVAR Treatment Of Complex AAAs And TAAAs: How Do They Work: Advantages And Limitations
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM DEBATE: Longer Follow-Up And Good Outcomes Support The Continued And Wider Use Of Parallel Graft Repairs Of Complex AAAs
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
8:30 AM - 8:35 AM DEBATE: Not So: Parallel Graft Use Should Be Decreasing: F/B/EVAR Is Best For Complex AAAs And TAAAs
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
8:36 AM - 8:41 AM Long-Term Results Of Chimney EVAR (Ch/EVAR) From The PERICLES Registry Show Good Results Comparable To F/EVAR: How Can These Results Be Duplicated And Devices Gain Approval For This Usage
  Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD  
  View Slides in PDF      
8:42 AM - 8:47 AM Endovascular Docking Station To Make Parallel Graft TAAA Repair Safe And Dependable And Avoid Gutter Endoleaks With 4-Parallel Grafts (2 Chimney And 2 Sandwich Grafts)
  Presenter(s):Manish Mehta, MD, MPH / James F. McKinsey, MD  
  View Slides in PDF      
8:48 AM - 8:53 AM 3-Vessel Parallel Grafts Can Yield Good Results For Complex AAA Repair If Certain Techniques Are Used: From The PERICLES Registry: Technical Tips
  Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD / Gergana Taneva, MD  
  View Slides in PDF      
8:54 AM - 8:59 AM How To Prevent Gutter Endoleaks With Parallel Grafts By The “Eye Of The Tiger” Technique: When Is It Needed And How To Do It
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
9:00 AM - 9:05 AM TAAA Repair With An Off-The-Shelf Multibranched Manifold Device: 7-Year Experience In < 100 Patients: Advantages, Limitations, Complications And Device Modifications To Avoid Them
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
9:06 AM - 9:15 AM Panel Discussion
9:15 AM - 9:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE ABOUT F/B/EVAR AND PARALLEL GRAFTS TO TREAT COMPLEX AAAs AND TAAAs
x
9:30 AM - 9:35 AM DEBATE: Why 2-Vessel F/EVAR Is Different And Less Complex Than 3- Or 4-Vessel F/EVAR: The Latter Requires Different Techniques, Has More Complications And Worse Results
  Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD  
  View Slides in PDF      
9:36 AM - 9:41 AM DEBATE: Not So: 4-Vessel F/EVARs Have Many Advantages In Many Patients And Are Not Substantially More Difficult
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
9:42 AM - 9:47 AM Many Bridging Stent-Grafts Are Now Available For F/B/EVAR Renal And Visceral Branches: Advantages And Limitations Of Each: Which Is Best In What Circumstance
  Presenter(s):Giovanni F. Torsello, MD / Giovanni Torsello, MD  
  View Slides in PDF      
9:48 AM - 9:53 AM For F/B/EVAR Treatment Of Complex AAAs And TAAAs What Are The Indications For And The Value And Disadvantages Of Fenestrations, Outer Branches And Inner Branches: Comparison Of Cook And Jotec Devices
  Presenter(s):Ciro Ferrer, MD / Piergiorgio Cao, MD, FRCS  
  View Slides in PDF      
9:54 AM - 9:59 AM F/B/EVAR To Treat Failed EVARs: What Are The Challenges: Technical Tips To Make A Difficult Procedure Easier
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM DEBATE: The Evidence To Support The Success And Durability Of Ch/EVAR For Complex AAAs Is Solid: If Done Right, Ch/EVAR Is Equal To F/EVAR And Has Real Advantages
  Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD  
  View Slides in PDF      
10:06 AM - 10:11 AM DEBATE: Not So: F/EVAR Is The Gold Standard For Complex AAAs And Has Better Outcomes: Ch/EVAR Is A Dying Procedure
  Presenter(s):Tara M. Mastracci, MD  
  View Slides in PDF      
10:12 AM - 10:17 AM What Anatomy Is Unsuitable For F/EVAR With The Cook Z-FEN Device: When Can This Device Be Used Successfully Outside Its IFU
  Presenter(s):Martin R. Back, MD  
  View Slides in PDF      
10:18 AM - 10:23 AM Technique For Safe Percutaneous Axillary Access For F/B/EVAR And Ch/EVAR Using Ultrasound, Closure Devices, Through And Through Wire And Balloon Control
  Presenter(s):Germano Melissano, MD / Luca Bertoglio, MD / Roberto Chiesa, MD  
  View Slides in PDF      
10:24 AM - 10:29 AM Update On The Value Of Variable Curvature Sheaths For F/B/EVAR: They Make Upper Extremity Access Largely Unnecessary And Decrease Radiation Exposure, Contrast Dose And Procedure Time
  Presenter(s):Joshua D. Adams, MD  
  View Slides in PDF      
10:30 AM - 10:35 AM Importance Of Secondary Procedures After F/B/EVAR: Indications, Type Of Interventions And Impact On Outcomes
  Presenter(s):Salvatore T. Scali, MD  
  View Slides in PDF      
10:36 AM - 10:45 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: A TRIBUTE TO OUR MILITARY AND SERVICE PHYSICIANS: MILITARY HISTORY, CONTROL AND TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES, CURRENT COMBAT CONDITIONS AND VALUE OF A TISSUE ENGINEERED VASCULAR GRAFT(6-MINUTE TALKS)
x
10:45 AM - 10:51 AM A Tribute To J. Leonel Villavicencio, MD (1927-2019): A Vascular Surgery Star And An Outstanding Military Surgeon
  Presenter(s):Eric A. Elster, MD  
  View Slides in PDF      
10:52 AM - 11:04 AM A Heroic Rescue And Battle From The War In Afghanistan: 20 US Airborne Army Rangers And 7 Navy SEALS Take On 400 Taliban Attackers And Win At Takurghar
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
11:05 AM - 11:11 AM What A Military Vascular Surgeon Is Currently Doing In Afghanistan And Why US Forces Must Stay There
  Presenter(s):Zachary M. Arthurs, MD  
  View Slides in PDF      
11:12 AM - 11:18 AM Comparison Of Current Treatments Of Combat And Civilian Vascular Injuries In Israel: When Open; When Endovascular
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
11:19 AM - 11:25 AM Role Of Military Medicine In Improving National Preparedness: Advances In Homeland Security And Department Of Defense Combat Casualty Care
  Presenter(s):Todd E. Rasmussen, MD, FACS / Eric A. Elster, MD  
  View Slides in PDF      
11:26 AM - 11:32 AM Advantages And Limitations Of Tourniquet Use In Military And Civilian Limb Vascular Trauma: Tourniquets Saves Lives If Used Properly
  Presenter(s):Michael Engelhardt, MD  
  View Slides in PDF      
11:33 AM - 11:39 AM The Humacyte Bioengineered Arterial Substitute For Traumatic Injuries And Other Vascular Lesions: Current Status Update And Value Of A Civilian-Military Partnership
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
  View Slides in PDF      
11:40 AM - 11:46 AM Updated Military Experience With REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) And Endovascular Resuscitation
  Presenter(s):Joseph J. DuBose, MD  
  View Slides in PDF      
11:47 AM - 11:53 AM Update On Civilian Use Of REBOA In Trauma And Other Conditions Including Cardiac Arrest: Advantages And Disadvantages
  Presenter(s):Tal M. Hörer, MD, PhD  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED ABDOMINAL AORTIC ANEURYSMS (RAAAs)
x
1:00 PM - 1:05 PM Value Of Telemedicine In The Management Of Patients With RAAAs
  Presenter(s):Nobuyoshi Azuma, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Risk Evaluation Scores And Systems Are Inaccurate And Do Not Help In The Management Of RAAA Patients: They Cannot Predict Patients Who Should Be Denied Treatment
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM With Adjuncts Such As Chimney Grafts And Onyx, 100% Of RAAA Patients Can And Should Be Treated By EVAR
  Presenter(s):Thomas Larzon, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM The Debate Is Over: EVAR Is The Best Treatment For RAAA Patients – Even If The RCTs Show Otherwise
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM The IMPROVE RCT Comparing EVAR To Open Repair For RAAAs Finally Showed Late Survival Is Better For EVAR: What Did The AJAX RCT Show Regarding Late Survival After RAAA Repair
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM EVAR Outcomes Are Improving In RAAA Patients: EVAR Should Be The Standard Of Care In Most RAAA Patients: Which RAAA Patients Currently Should Get Open Repair
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM Techniques For Rapid Percutaneous Access And Quick Contralateral Gate Cannulation In RAAA Patients: Technical Tips
  Presenter(s):Felice Pecoraro, MD / Mario L. Lachat, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM How Should Aortic Endografts Be Sized In Hypotensive RAAA Patients: CTA Measurements May Be Misleading
  Presenter(s):Zoran Rancic, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:53 PM Why Have Survival Rates For RAAA Patients Improved In Recent Years: It Is Not Just The Increasing Use Of EVAR
  Presenter(s):Martin Bjorck, MD, PhD / 
  View Slides in PDF      
1:54 PM - 2:00 PM Why The Endologix Ovation Alto Device Has Advantages For EVAR Treatment Of RAAAs: It Eliminates The Need For Supraceliac Aortic Balloon Control: How So
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
2:00 PM - 2:08 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE NEW DEVELOPMENTS IN THE TREATMENT OF RAAAs AND RUPTURED JUXTA- AND PARARENAL AAAs AND TAAAs
x
2:08 PM - 2:13 PM After EVAR For RAAAs Sac Shrinkage Is Greater Than After Elective EVAR: But Survival Is Similar: What Are The Explanations
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:14 PM - 2:19 PM Update On Improvements In The Diagnosis And Treatment Of Abdominal Compartment Syndrome (ACS) After EVAR For RAAAs
  Presenter(s):Martin Bjorck, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
2:20 PM - 2:25 PM DEBATE: Surgeon Modified Endografts Or Off-The-Shelf Devices Are The Best Way To Treat Ruptured Complex AAAs (Juxta- Or Pararenal)
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
  View Slides in PDF      
2:26 PM - 2:31 PM DEBATE: Not So: Ch/EVAR Is The Best Way To Treat Ruptured Complex AAAs
  Presenter(s):Mario L. Lachat, MD / Konstantinos P. Donas, MD / Drosos Kotelis, MD  
  View Slides in PDF      
2:32 PM - 2:37 PM Periodontal Inflammatory Disease With Gram Negative Pockets May Cause Rapid AAA Growth And Instability: How Should It Be Treated In Patients With Small AAAs
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
2:38 PM - 2:43 PM Finnish Nationwide Study Shows That Most RAAA Patients Never Reach A Hospital And Many RAAA Patients Are Not Picked Up By AAA Screening: Are These Findings True In Other Countries And How Can They Be Fixed
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
2:44 PM - 2:49 PM In Japan: EVAR Is The Best Treatment For RAAAs: The Surprising Significance Of Retroperitoneal Hematoma Volume
  Presenter(s):Naoki Fujimura, MD, PhD  
  View Slides in PDF      
2:50 PM - 2:55 PM Total Endovascular Repair Of Ruptured TAAAs: What Graft Is Best: Why These Ruptures Are Usually Contained And Slowly Evolving: Technical Tips
  Presenter(s):Gianluca Faggioli, MD / Mauro Gargiulo, MD / Andrea Stella, MD  
  View Slides in PDF      
2:56 PM - 3:01 PM Endovascular Repair Of Ruptured TAAAs: European Multicenter Results: What Endografts Were Used: Management And Technical Tips
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
3:02 PM - 3:10 PM Panel Discussion
3:10 PM - 3:20 PM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: EXCITING NEW OR IMPROVED TECHNIQUES, CONCEPTS AND DEVICES; UPDATES ON EVOLVING ENDOVASCULAR TREATMENTS
x
3:20 PM - 3:25 PM Improved Less Invasive Technique For Anterior Lumbar Spine Exposure For Interbody Fusion: Complications And How To Avoid Them
  Presenter(s):Christian Ochoa, MD  
  View Slides in PDF      
3:26 PM - 3:31 PM Endovascular Treatment Of Vascular Complications Of Kidney Transplantation: These Complications Are More Frequent Than One Might Think
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
3:32 PM - 3:37 PM How Computational Fluid Dynamic Analyses Can Help In Determining The Optimal Treatment Of Aortic Lesions
  Presenter(s):James C. Stanley, MD / C. Alberto Figueroa, PhD / Christopher Tossas, BS / Theodorus van Bakel, MD, PhD  
  View Slides in PDF      
3:38 PM - 3:43 PM Use Of Thoracic Stent-Grafts To Control Major Iliac Vein Or Caval Bleeding From Trauma Or During Open Surgery: How To Do It
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Slides in PDF      
3:44 PM - 3:49 PM Technical Tips For Safe Antegrade Common Femoral Artery (CFA) Access: It Should Have Similar Complication Rates To Standard Retrograde CEA Access: From The VQI
  Presenter(s):Jeffrey J. Siracuse, MD, RPVI, FACS  
  View Slides in PDF      
3:50 PM - 3:55 PM The Aortyx Patch: What Is It And How Does It Work To Repair Focal Aortic Defects With Loss Of Tissue
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
3:56 PM - 4:01 PM A Sirolimus External Patch To Prevent Anastomotic Intimal Hyperplasia When Placed Around The Distal Anastomosis Of A PTFE Fempop Arterial Graft
  Presenter(s):Sriram S. Iyer, MD, FACC  
4:02 PM - 4:07 PM Panel Discussion
4:07 PM - 4:12 PM Left Gastric Embolization To Treat Obesity: Indications, Technique And How Effective Is It
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
  View Slides in PDF      
4:13 PM - 4:18 PM Current Status Of Prostate Artery Embolization For Benign Prostatic Hypertrophy: Will It Replace Surgery; Technical Requirements And Results From A Meta-Analysis
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
4:19 PM - 4:24 PM Occlusion Perfusion Catheter (From Advanced Catheter Therapies) To Inject Paclitaxel Or Other Drugs Into The Arterial Wall After Atherectomy: How Does It Work And 1-Year Results
  Presenter(s):Lawrence A. Garcia, MD / George L. Adams, MD  
  View Slides in PDF      
4:25 PM - 4:30 PM Preservation Of A Favorable Aortic Bifurcation During AAA Repair (Open And Endo) To Facilitate Later Contralateral Approaches For Lower Extremity Occlusive Disease: How To Do It
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
4:31 PM - 4:36 PM Mini-Incision Open AAA Repair: When And How To Do It
  Presenter(s):Kamphol Laohapensang, MD  
  View Slides in PDF      
4:37 PM - 4:42 PM External Support Of Vein Grafts For Lower Extremity Bypasses: When Is It Helpful And How To Do It
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
4:43 PM - 4:48 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: MORE ABOUT NEW CONCEPTS, DEVICES AND TECHNIQUES; PROGRESS IN RADIATION SAFETY
x
4:48 AM - 4:53 AM V-Healthy And V-Awareness Programs To Enhance Public Awareness Of Vascular Diseases And What Can Be Currently Done To Treat It Effectively
  Presenter(s):Manish Mehta, MD, MPH  
  View Slides in PDF      
4:54 PM - 4:59 PM Status Of Credentialing For Vascular Outpatient Centers And OBLs: What Organization Or Society Is Leading The Initiative
  Presenter(s):Anton N. Sidawy, MD, MPH  
  View Slides in PDF      
5:00 PM - 5:05 PM How To Do Perfusion Angiography To Assess Foot Circulation And Adequacy Of Treatment: Value In Diabetic Gangrene And Ulceration
  Presenter(s):Jim Reekers, MD, PhD  
  View Slides in PDF      
5:06 PM - 5:11 PM How To Create A Poor Man’s Variable Curve/Deflection Sheath That Is Stable: How To Make It And Value In F/B/EVAR: It Can Minimize The Need For Axillary Access
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
5:12 PM - 5:17 PM A New EVAR Endograft With Thrombogenic Fibers: It Decreases Endoleaks And Promotes Sac Shrinkage: How Does It Work And Favorable 2-Year Results (Kardiozis From Affluent Medical)
  Presenter(s):Dominique Fabre, MD  
  View Slides in PDF      
ADVANCES IN RADIATION SAFETY
5:18 PM - 5:23 PM New Developments In Radiation Safety To Decrease Exposure To The Staff And Patients: What Is Claimed To Work But Does Not And What Works
  Presenter(s):Lindsay Machan, MD  
  View Slides in PDF      
5:24 PM - 5:29 PM How Can Simulation Help To Promote Radiation Safety For Operators And Staff Members
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
5:30 PM - 5:35 PM New Methods To Quantitate And Minimize Radiation Exposure To Personnel During Endovascular Procedures: Why Consequences From Given Exposure Vary Between Individuals: Can This Variability Be Determined
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
5:36 PM - 5:41 PM What Is New In Radiation Protection For Pregnant Physicians, Other Staff Members And Patients
  Presenter(s):Palma M. Shaw, MD  
  View Slides in PDF      
5:42 PM - 5:47 PM Technical Tips And New Technologies To Decrease Radiation Exposure During Complex Aortic Procedures: IVUS, Fusion, Virtual Reality, New Non-Xray Endovascular Guidance Systems
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
5:48 PM - 5:53 PM Radiation Treatment For Lung Or Esophageal Cancer Can Cause Aortic Ruptures: Endografts Can Prevent Or Treat The Problem
  Presenter(s):Maciej L. Dryjski, MD, PhD  
  View Slides in PDF      
5:54 PM - 6:02 PM Panel Discussion
End of Program G

END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR IMPROVED DEVICES FOR STANDARD INFRARENAL EVAR PROCEDURES AND STRATEGIES FOR OPEN AAA REPAIR TRAINING
x
6:45 AM - 6:50 AM Current Status Of The Treo Endograft (Terumo Aortic) For EVAR In Europe And The US: Advantages And Limitations
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
6:51 AM - 6:56 AM The Altura Endograft For EVAR Repairs Of Standard Infrarenal AAAs: It Has A Double D Configuration In The Proximal Neck: Advantages, Limitations And 5-Year Results
  Presenter(s):Dainis K. Krievins, MD / Albrecht H. Kramer, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Updated 2-Year Results Of The LEOPARD RCT Comparing The AFX (Endologix) Endograft To Other Standard Endografts For AAA Repair
  Presenter(s):Christopher J. Kwolek, MD, MBA  
  View Slides in PDF      
7:03 AM - 7:08 AM Will Newer Lower Profile EVAR Devices Make A Positive Or Negative Difference On Outcomes And Availability Of EVAR
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
7:09 AM - 7:14 AM There Are Fewer Type 2 Endoleaks With The Gore Excluder Endograft Than Other EVAR Devices: What Is The Reason
  Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC  
  View Slides in PDF      
7:15 AM - 7:20 AM Update On The Ovation Polymer Based Endograft (Endologix) Without And With Chimney Grafts: Advantages, Limitations And 5-Year Results
  Presenter(s):Venkatesh G. Ramaiah, MD  
  View Slides in PDF      
7:21 AM - 7:26 AM Why The ALTO (Ovation) Endograft Has Advantages For AAA Repair: How Does Raising Its Polymer Proximal Sealing Ring Improve EVAR Applicability Based On Early Results
  Presenter(s):Sean P. Lyden, MD  
  View Slides in PDF      
7:27 AM - 7:33 AM Panel Discussion
7:33 AM - 7:38 AM Long-Term (10-Year) Follow-Up After EVAR With The Cook Zenith Endograft Shows It To Be Durable And Effective: Are There Any Downsides
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
7:39 AM - 7:44 AM Update On The Cook Alpha Device For EVAR: Advantages, Limitations And Results
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM The Gore Conformable Excluder With Active Proximal (Neck) Angulation Control: Results Of US IDE Trial To Date: Advantages And Limitations
  Presenter(s):Robert Y. Rhee, MD  
  View Slides in PDF      
7:51 AM - 7:56 AM European Results With The Gore Conformable AAA Endograft With Active Proximal Angulation Control
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
7:57 AM - 8:02 AM The Low Profile Incraft (From Cordis-Cardinal Health) For EVAR Has Real Advantages Based On Midterm Results From The Italian Multicenter Experience: The Device Is Now FDA Approved
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD / Franco Grego, MD  
  View Slides in PDF      
8:03 AM - 8:08 AM How Use Of Regional Referral Centers Can Remedy The Shortfall Of Vascular Surgical Training In Open AAA Repair In The EVAR, F/EVAR Era
  Presenter(s):Lee Kirksey, MD  
  View Slides in PDF      
8:09 AM - 8:15 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: MORE NEW OR UPDATED INFORMATION ABOUT NON-STANDARD DEVICES FOR EVAR OR ENDOVASCULAR ANEURYSM SEALING (EVAS) (TALKS ARE 4 3/4 OR 5 MINUTES)
x
8:15 AM - 8:20 AM Why AAA Sac Filling Endografts Like Nellix May Be Better Devices For Endo AAA Repair: What Are Their Disadvantages
  Presenter(s):Venkatesh G. Ramaiah, MD  
  View Slides in PDF      
8:21 AM - 8:26 AM Prevention Of Endoleaks After EVAR With A New Sac Filling Polymer Based Device: How It Works And What Is Its Status
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
8:27 AM - 8:32 AM Advantages Of The Ovation Endograft (Endologix) For AAA Repair: Why The Polymer Filled Sealing Rings Are A Better Way To Secure And Maintain A Proximal Seal: Value Of The New Alto Modification
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
8:33 AM - 8:38 AM Status Report On The Endologix Nellix Endograft For EVAS: Advantages, Limitations, Precautions And When Should It Be Used
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
8:39 AM - 8:44 AM Evolution Of Nellix And EVAS: From A Single Center 295-Patient Experience: Advantages And Limitations
  Presenter(s):Pete Holt, MD, PhD / 
  View Slides in PDF      
8:45 AM - 8:50 AM Panel Discussion
8:50 AM - 8:55 AM Pros And Cons Of Nellix EVAS: From An Early Enthusiast: What Is Its Future And How Does It Decrease Post-Procedure Mortality
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
8:56 AM - 9:01 AM Current Role And Value Of Nellix EVAS In A Busy EVAR Practice: How Best To Detect And Manage Failures
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
9:02 AM - 9:07 AM Nellix In Nellix Procedure For Failed EVAS: Technical Challenges And Tips To Overcome Them
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
9:08 AM - 9:13 AM What Are The Definitive Advantages Of EVAS That Prompt Its Continued Use
  Presenter(s):Daniel G. Clair, MD  
  View Slides in PDF      
9:14 AM - 9:19 AM Chimney EVAS: When Should It Be Used: Advantages And Technical Tips To Do It Safely And Effectively
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Slides in PDF      
9:20 AM - 9:26 AM Panel Discussion
9:26 AM - 9:40 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING ANEURYSMS AND OTHER LESIONS IN OR NEAR THE AORTIC ARCH (5-MINUTE TALKS)
x
9:40 AM - 9:45 AM Update On The Nexus Off-The-Shelf Single Branch Device For Treating Lesions Involving The Entire Aortic Arch (Zone 0 Lesions): Unique Advantages, Precautions And Midterm Results
  Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM Terumo Aortic 2 Inner Branched Relay Device For Treating Aortic Arch Lesions: Advantages, Limitations And Early Registry Results
  Presenter(s):Piergiorgio Cao, MD, FRCS / Ciro Ferrer, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM Gore Single Branched Device For Revascularizing The Left Subclavian Artery For Aortic Lesions Near The Arch Or More Complex Arch Lesions: Current Status, Advantages, Precautions And Results
  Presenter(s):Michael D. Dake, MD / Michel Makaroun, MD  
  View Slides in PDF      
9:58 AM - 10:03 AM Medtronic Valiant Mona LSA Single Branch Endograft For TEVAR Treatment Of Aortic Lesion Involving Or Near To The Left Subclavian Artery: Advantages, Precautions And Midterm Results
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
10:04 AM - 10:09 AM More About The Valiant Mona LSA Single Branched TEVAR Device: Why Use It In Preference To A Chimney Or Periscope Parallel Graft
  Presenter(s):Herve Rousseau, MD, PhD  
  View Slides in PDF      
10:10 AM - 10:15 AM Custom-Made Scallops In Relay TEVAR: Results Of The French “REP” Study: A Step Forward To An Off-The-Shelf Device
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
10:16 AM - 10:22 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING DESCENDING AORTIC LESIONS (TEVAR) AND TAAAs (5-MINUTE TALKS)
x
10:22 AM - 10:27 AM Is TEVAR Device Integrity Compromised By Low Profile Devices
  Presenter(s):James H. Black III, MD  
  View Slides in PDF      
10:28 AM - 10:33 AM Long-Term Outcomes Of TEVAR With Low Profile Devices: Which Ones Are Durable; Which Are Not
  Presenter(s):Giovanni F. Torsello, MD / Giovanni Torsello, MD / Martin J. Austermann, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM How Does The New Valiant Navion Low Profile Endograft Expand The Therapeutic Options For TEVAR: Early Experience
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM Valiant Navion Low Profile And Captiva Devices (From Medtronic) For TEVAR: Advantages For Various Aortic Lesions
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
10:46 AM - 10:51 AM Value Of The New Low Profile Relay Pro Endograft (From Terumo Aortic) For TEVAR In Patients With Thoracic Aortic Aneurysms And Dissections: Advantages Over The Relay Plus Device
  Presenter(s):Edward Y. Woo, MD / Vicente Riambau, MD, PhD  
  View Slides in PDF      
10:52 AM - 10:57 AM Advantages Of The Relay Plus Endograft For TEVAR: Why Does It Have A Lower Stroke Rate Than Other TEVAR Devices
  Presenter(s):Mahmoud B. Malas, MD, MHS / Vicente Riambau, MD, PhD  
  View Slides in PDF      
10:58 AM - 11:03 AM Value Of The Relay Pro Low Profile Device For TEVAR In Blunt Thoracic Aortic Injuries: Why It Is Advantageous
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
11:04 AM - 11:09 AM Advantages Of A New Gore Conformable C-Tag Endograft For TEVAR: It Has Active Proximal Angulation Control To Deal With Complex Aortic Arch Angles; And Staged Deployment To Avoid Aortic Flow Interruption And Get Accurate Positioning Without The Need For Rapid Pacing
  Presenter(s):Dittmar Boeckler, MD / Giovanni Torsello, MD  
  View Slides in PDF      
11:10 AM - 11:17 AM Panel Discussion
11:17 AM - 11:22 AM Update On Worldwide Results With The Anaconda Fenestrated Endograft For Repair Of Juxta- And Pararenal AAAs: Advantages And Limitations: From The FACT Registry
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
NEW ENDOVASCULAR DEVICES TO TREAT TAAAs
11:23 AM - 11:28 AM New Hybrid Device (Open And Endo) To Treat TAAAs: Thoracoflo From Terumo Aortic: How It Works, Advantages And Early Clinical Results
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
11:29 AM - 11:34 AM The Gore TAMBE Endovascular Device To Treat TAAAs: Device Evolution, Current Status, Advantages And Results
  Presenter(s):Mark A. Farber, MD / Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
11:35 AM - 11:40 AM The Valiant Off-The-Shelf Manifold Device (From Medtronic) For Treating TAAAs: How Does It Work, Advantages, Early Clinical Experience And Present Status
  Presenter(s):Murray L. Shames, MD / Patrick W. Kelly, MD  
  View Slides in PDF      
11:41 AM - 11:46 AM Update On The Colt Multibranched Manifold Device For Treating TAAAs: Clinical Experience And Present Status
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
11:47 AM - 11:52 AM Physician Modifications To The Excluder Endograft To Make It Effective For Treating TAAAs: Technique And Results
  Presenter(s):Wayne W. Zhang, MD  
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR UPDATED INFORMATION ON LOWER EXTREMITY PROSTHETIC GRAFTS OR STENT-GRAFTS FOR TREATMENT OF OCCLUSIVE DISEASE AND OTHER USES; VALUE OF HYBRID GRAFTS (PARTIALLY STENTED) FOR RENAL-VISCERAL DEBRANCHING (SEE ALSO SESSION 28)
x
1:00 PM - 1:05 PM Cryopreserved Vein Allografts For Lower Extremity Bypasses: Indications, Value, Advantages And Limitations
  Presenter(s):Robyn A. Macsata, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Increasing Usage And Value Of Covered Stents Are Facilitated By Newly Available Devices: What Are The New Devices And What Benefits Do They Provide
  Presenter(s):Paulo E. Ocke Reis, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Broadening Applications And Value Of Balloon Expandable Covered Stents: The VBX Covered Stent From Gore
  Presenter(s):W. Anthony Lee, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Value Of The VBX Balloon Expandable Stent-Graft In Treating Challenging Aorto-Iliac Occlusive Lesions: 3-Year Results, Advantages And Limitations
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Advantages Of Balloon Expandable Covered Bridging Stents In F/B/EVAR Procedures: Which One Is Best And Why
  Presenter(s):Mauro Gargiulo, MD / Gianluca Faggioli, MD / Andrea Stella, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Positive 3-Year Results With The iCAST Balloon Expandable Covered Stents For Iliac Occlusive Disease: From The iCARUS Trial Comparing Them To VBX FLEX And Bolster Covered Stents
  Presenter(s):John R. Laird, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Value Of Gore Hybrid Partially Stented PTFE Stent-Graft For Renal And Visceral Debranching Procedures To Treat Complex AAAs: How To Use Them
  Presenter(s):Francesco Setacci, MD  
  View Slides in PDF      
1:42 PM - 1:48 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR UPDATED DEVICES FOR LOWER EXTREMITY TREATMENTS: STENTS, BALLOONS, TACKS AND ATHERECTOMY DEVICES
x
1:48 PM - 1:53 PM 2-Year Follow-Up Findings And Results From The Lutonix BTK DCB Global Registry
  Presenter(s):Michael K.W. Lichtenberg, MD / Dierk Scheinert, MD  
  View Slides in PDF      
1:53 PM - 1:58 PM Novel Angioplasty Balloon With Integrated Distal Embolic Protection Filter (Vanguard System From Contego Medical) For Use With Lesions Having High Embolic Potential: How It Works And Results Of The ENTRAP Study
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
1:58 PM - 2:03 PM Update On Results And Value Of The Chocolate Touch DCB (QT Vascular - Medtronic) To Minimize Dissection During Balloon Angioplasty
  Presenter(s):Jos C. van den Berg, MD, PhD / Mehdi H. Shishehbor, DO, MPH, PhD  
  View Slides in PDF      
2:03 PM - 2:08 PM The Biomimics 3D Helical Swirling Flow Inducing Stent (From Veryan Medical): 2-Year Results Of The MIMICS-2 Trial Show It Works Well For Complex Fempop Lesions: Now FDA Approved
  Presenter(s):Thomas Zeller, MD / Peter Gaines, MD / Timothy M. Sullivan, MD / Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
2:08 PM - 2:13 PM What Is The Ideal Stent To Use When Fempop Angioplasty With A DCB Fails Early; Late
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
2:13 PM - 2:18 PM The Tigris Dual Component Stent (PTFE/Nitinol – From Gore): Is It Better And Why: Results From Multicenter Registries
  Presenter(s):Maria A. Ruffino, MD, EBIR / Martin Werner, MD  
  View Slides in PDF      
2:19 PM - 2:29 PM Panel Discussion
2:29 PM - 2:34 PM Tack Optimized Balloon Angioplasty With The Tack Endovascular System (From Intact Vascular) To Eliminate Dissections After Angioplasty: How Does This Device Work; Why It Is Better Than Stents; The TOBA Trials Show It Works Above The Knee: Now FDA Approved
  Presenter(s):Marianne Brodmann, MD / Peter A. Schneider, MD  
  View Slides in PDF      
2:34 PM - 2:39 PM How Well Does The Tack Endovascular System Work With BTK Balloon Angioplasty: TOBA II BTK-Pivotal Trial Results For A BTK Tack Implant
  Presenter(s):Patrick J. Geraghty, MD / George L. Adams, MD  
  View Slides in PDF      
2:39 PM - 2:44 PM Management Of Arterial Dissections Following PTA Is Cost Effective: Results Of An Analysis With The Intact (Tack) Vascular Device
  Presenter(s):Peter A. Schneider, MD / Michael R. Jaff, DO  
  View Slides in PDF      
PROGRESS IN ATHERECTOMY
2:44 PM - 2:49 PM The Phoenix Atherectomy System (From Volcano-Philips): What Makes It Different And Possibly Better Than Other Atherectomy Devices
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
2:49 PM - 2:54 PM IVUS Directed Atherectomy Of BTK Lesions With The Phoenix Atherectomy (ATX) Device: Why It Works Better Than Other ATX Devices: Technical Tips And Results Of The PRESTIGE PILOT Trial
  Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Jetstream Atherectomy (Boston Scientific) With Active Aspiration And DCBs For Use With DCBs For Complex SFA Lesions: What Makes It Different And Advantageous: Technical Tips
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
2:59 PM - 3:04 PM Value Of Lithotripsy, Orbital Atherectomy (From CSI) And DCBs For Long Calcified BTK Occlusive Lesions: How Do They Work In Concert And Why Do They Promise Good Results
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
3:04 PM - 3:09 PM Improvements In The Turbopowered Laser Atherectomy Device (From Philips): What Makes It Different: How Does It Work With Various Lesion Pathologies: 12-Month Results And IVUS Evaluations
  Presenter(s):George L. Adams, MD  
  View Slides in PDF      
3:09 PM - 3:15 PM Panel Discussion
3:15 PM - 3:25 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: UPDATES ON ANCHORING DEVICES (ENDOANCHORS) TO PREVENT OR TREAT ENDOLEAKS WITH EVAR OR TO PREVENT DEVICE MIGRATION
x
ENDOANCHORS AND EVAR
3:25 PM - 3:30 PM New Developments With Endoanchors (Aptus-Medtronic): New Evidence That Endoanchors Can Facilitate And Maintain Successful Standard EVAR For AAAs With Short Or Angulated Necks Without Increasing Costs: From The ANCHOR Registry
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
3:31 PM - 3:36 PM When Are Endoanchors Indicated And When Are They Contraindicated: Causes Of Failure And Technical Tips For Optimal Use
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
3:37 PM - 3:42 PM Computational Analysis Of AAA Neck Seal Zone Preservation With EVAR And Predicting The Need For Endoanchors To Prevent Migration With Imperfect Necks: Is It Valid
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
3:43 PM - 3:48 PM Sac Regression Is Important, And Endoanchors May Be Of Benefit In Hostile Necks
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
3:49 PM - 3:54 PM How Can 3D Fusion Imaging Help In Precision Deployment Of Endoanchors: Does It Improve Outcomes
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM With Hostile Neck Anatomy Endoanchors Prevent Neck Related Complications – Dilatation, Endoleaks And Migration: What Is The Proof: From The ANCHOR Registry
  Presenter(s):Apostolos K. Tassiopoulos, MD  
  View Slides in PDF      
4:01 PM - 4:06 PM When Can Endoanchors Placed Secondarily Fix Established Type 1A Endoleaks After EVAR: And When Can’t They: What Is The Durability Of Endoanchor Fixes
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
ENDOANCHORS AND TEVAR
4:07 PM - 4:12 PM Value Of Endoanchors To Fix Type 1 Endoleaks After TEVAR
  Presenter(s):Piotr M. Kasprzak, MD  
  View Slides in PDF      
4:13 PM - 4:18 PM Value Of Endoanchors With TEVAR: They Decrease The Incidence Of Type 1 Endoleaks And Migration: When Should They Be Used
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:19 PM - 4:25 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW OR IMPROVED DEVICES FOR REMOVING DISEASE RELATED OR IATROGENIC CLOT; NEW DEVICES FOR INTRA-ARTERIAL EMBOLIZATION (4 ¾- MINUTE TALKS)
x
CLOT REMOVING DEVICES
4:25 PM - 4:30 PM Inari ClotTriever Device For Quick Removal Of Large Amounts Of Intravascular Clot From Large Arteries And Veins: How Does It Work And Advantages
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Value Of The Rotarex Device (Straub Medical) For Removing Thrombus And Atheromatous Material From Fempop Occlusions: Advantages, Limitations And Technical Tips
  Presenter(s):Michael K.W. Lichtenberg, MD / Christian Wissgott, MD  
  View Slides in PDF      
4:35 PM - 4:40 PM New Findings For Removing Clot With Microbubbles Ultrasound And Thrombolytic Drugs: Its Safer And More Efficient Than Other Lytic Methods
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
4:40 PM - 4:45 PM Latest Innovations And Advances In Endovascular Power Clot Removal/Aspiration: How They Work And Why They Work Better Than Older Devices
  Presenter(s):James F. Benenati, MD  
  View Slides in PDF      
4:45 PM - 4:50 PM Pros And Cons Of Percutaneous Clot Removal Techniques: When Do They Work And When Don’t They
  Presenter(s):Laura Capoccia, MD, PhD / Michel Rossi, MD  
  View Slides in PDF      
4:50 PM - 4:55 PM Update On The Treatment Of Acute Limb Ischemia: Advantages And Limitations Of The New Endovascular Devices: Are Open Techniques Ever Required
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
4:55 PM - 5:00 PM The New Endovascular Pharmaco-Mechanical Thrombectomy Devices: How Each Works And Advantages Of Each Device And When Is Each Best
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
5:00 PM - 5:06 PM Panel Discussion
5:06 PM - 5:11 PM Update On New Technologies For Percutaneous Arterial Clot Aspiration: How Each Works And How Best To Use It: Technical Tips And Limitations
  Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD  
  View Slides in PDF      
5:11 PM - 5:16 PM Multiple Uses Of The Indigo Percutaneous Clot Aspiration System (From Penumbra): How It Works And Why It Simplifies Treatment And Improves Outcomes
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
5:16 PM - 5:21 PM Value Of Arterial Thrombolysis In Patients With Contraindications: How To Do It With Reasonable Safety
  Presenter(s):Anil P. Hingorani, MD  
  View Slides in PDF      
5:21 PM - 5:26 PM Improving Outcomes Of Treatment Of Long Segment Fempop Chronic Occlusions (CTOs) With Initial Indigo Clot Aspiration Before Definitive Use Of A DCB Or Stent
  Presenter(s):Mazin Foteh, MD  
  View Slides in PDF      
5:27 PM - 5:32 PM Mechanical Percutaneous Aspiration Thrombectomy With The Indigo System Is Safe And Effective In Treating Acute Limb Ischemia: When Is It Not: From the Multicenter INDIAN Registry
  Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD  
  View Slides in PDF      
ADVANCES IN EMBOLOTHERAPY
5:33 PM - 5:38 PM Endovascular Treatment Of Visceral And Renal Aneurysms With Detachable Coils: Technical Tips, Limitations And Results
  Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR  
  View Slides in PDF      
5:39 PM - 5:44 PM How To Manage Serious Hemorrhage With Newer Coils And Liquid Embolic Agents
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
  View Slides in PDF      
5:45 PM - 5:52 PM Panel Discussion
End of Program H

END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:00 AM - 7:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:05 AM - 7:10 AM Classification Of Chronic Venous Disease: CEAP, VCSS And Beyond
  Presenter(s):Marc A. Passman, MD  
  View Slides in PDF      
7:11 AM - 7:16 AM VCSS Versus Villata – Pros And Cons As An Outcome Measure
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
7:17 AM - 7:22 AM Physiology Of Venous Return
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
7:23 AM - 7:28 AM Analysis Of Biofluids From Patients With CVD
  Presenter(s):Sarah Onida, MD, PhD  
  View Slides in PDF      
7:29 AM - 7:34 AM Lower Limb Venous Kinetics And Impact On Venous Drainage
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
  View Slides in PDF      
7:35 AM - 7:40 AM An Algorithm To Predict Disease Severity In C2 Patients
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
7:41 AM - 7:46 AM Evidence Summary On The Pathophysiology Of Varicose Veins
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
7:47 AM - 7:52 AM Understanding Effects Of External Positive And Negative Pressure On The Venous System
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
7:53 AM - 7:58 AM Non-Venous Causes Of The Swollen Extremity
  Presenter(s):Andrea T. Obi, MD  
  View Slides in PDF      
7:59 AM - 8:04 AM Superficial Reflux With Obstructed Deep Veins: When And When Not To Treat
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
8:05 AM - 8:10 AM Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
8:11 AM - 8:16 AM Panel Discussion
END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS IMAGING TECHNIQUES
x
8:17 AM - 8:22 AM Identifying Reflux Pathways With Duplex Ultrasound Mapping
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
8:23 AM - 8:28 AM Iliocaval Duplex Ultrasound With Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
  View Slides in PDF      
8:29 AM - 8:34 AM Getting A Look At Inflow With Duplex Ultrasound Prior To Endovascular Reconstruction Of Post-Thrombotic Iliocaval Disease
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
8:35 AM - 8:40 AM MRV And Major Venous Interventions
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
8:41 AM - 8:46 AM Single Center Retrospective Review Of Patients With Iliac Thrombosis Who Underwent CT And DUS .... Showing The Limitations Of DUS
  Presenter(s):Heron E. Rodriguez, MD  
  View Slides in PDF      
8:47 AM - 8:52 AM Value Of IVUS And Other Techniques To Improve The Diagnosis And Treatment Of Iliofemoral Occlusion
  Presenter(s):Erin H. Murphy, MD  
  View Slides in PDF      
8:53 AM - 8:58 AM Detailed Anatomy Of The Gastrocnemius And Soleus Veins Based On CT-Venography
  Presenter(s):Evgeny Shaydakov, MD, PhD  
  View Slides in PDF      
8:59 AM - 9:04 AM The VIDIO Trial Comparing IVUS Versus Multiplanar Venogram For Diagnosing Iliofemoral Vein Obstruction
  Presenter(s):Paul J. Gagne, MD  
  View Slides in PDF      
9:05 AM - 9:10 AM Transillumination Phleboscopy: What Do We Need To Avoid
  Presenter(s):Gutenberg A. Gurgel, MD  
  View Slides in PDF      
9:11 AM - 9:16 AM Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
9:17 AM - 9:22 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:23 AM - 9:28 AM Venous Drugs And Do They Work – The Colombian Experience
  Presenter(s):Jorge H. Ulloa, MD, FACS  
  View Slides in PDF      
9:29 AM - 9:34 AM What Drugs Do I Recommend For Symptomatic Venous Disease
  Presenter(s):Alberto C. Duque, MD  
  View Slides in PDF      
9:35 AM - 9:40 AM "Choosing Wisely" Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence
  Presenter(s):Claudine M. Hamel-Desnos, MD  
  View Slides in PDF      
9:41 AM - 9:46 AM Truncal Vein Diameters Should Not Be Used As A Rationing Tool
  Presenter(s):Sarah Onida, MD, PhD  
  View Slides in PDF      
9:47 AM - 9:52 AM Combined Ablation Plus Phlebectomy Is Associated With Improvements In Venous Outcomes
  Presenter(s):Nicholas H. Osborne, MD, MS  
  View Slides in PDF      
9:53 AM - 9:58 AM Long-Term (25 Years) Results Of Venopreserving Operations
  Presenter(s):Evgeny Shaydakov, MD, PhD  
  View Slides in PDF      
9:59 AM - 10:04 AM Polidocanol Foam Sclerotherapy Of Lymphoceles After Varicose Vein Surgery: An Effective And Safe First-Choice Treatment
  Presenter(s):Lourdes Reina, MD  
  View Slides in PDF      
10:05 AM - 10:10 AM Do You Need To Treat EHIT 2
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:11 AM - 10:16 AM SVT In The Pregnant Patient
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
10:17 AM - 10:22 AM Saphenous Vein Histopathology 5.5 Years After Cyanoacrylate Closure
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
10:23 AM - 10:28 AM Radiofrequency And Laser Vein Ablation For Patients On Anticoagulation Is Safe, Effective, And Durable
  Presenter(s):Glenn Jacobowitz, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: THERMAL AND NON-THERMAL ABLATION
x
10:35 AM - 10:40 AM Ultrasound Guided Foam Sclerotherapy: What We Should Know
  Presenter(s):Jean Luc Gerard, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM Is Thermal Ablation Obsolete
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
10:47 AM - 10:52 AM Radiofrequency Ablation: Something New
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:53 AM - 10:58 AM VenaSealTM Closure System Post Procedure Care
  Presenter(s):Brian Ferris, MD  
  View Slides in PDF      
10:59 AM - 11:04 AM Proprietary Polidocanol Microfoam: What We Should Know
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
11:05 AM - 11:10 AM SECURE Trial Update
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
11:11 AM - 11:16 AM New Venous Closure Devices: Mechanical
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
11:17 AM - 11:22 AM Contraindications And Limits: MOCA
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
11:23 AM - 11:28 AM Contraindications And Limits: Laser
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
11:29 AM - 11:34 AM Contraindications And Limits: Radiofrequency Ablation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
11:35 AM - 11:40 AM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
x
11:41 AM - 11:46 AM Morel Lavallée Syndrome
  Presenter(s):Jean Luc Gerard, MD  
  View Slides in PDF      
11:47 AM - 11:52 AM Laser Or Ohmic Devices For Telangiectasia: When And Why
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
11:53 AM - 11:58 AM Phlebectomy: Step By Step
  Presenter(s):Saum A. Rahimi, MD  
  View Slides in PDF      
11:59 AM - 12:04 PM Ablative Risks Prior And After Flying: What Do You Tell Your Patients
  Presenter(s):Sarah Onida, MD, PhD  
  View Slides in PDF      
12:05 PM - 12:10 PM Foam Therapies (PCF Vs PEM): When To Use And Does It Make A Difference
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
12:11 PM - 12:16 PM How To Treat Labial Varices: Sclerotherapy, USG Sclerotherapy And/Or Phlebectomy
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
12:17 PM - 12:22 PM Should All Saphenous Recanalizations Be Treated
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
12:23 PM - 12:28 PM Laser And/Or Sclerosant For Cosmetic Veins: How And Why
  Presenter(s):Gutenberg A. Gurgel, MD  
  View Slides in PDF      
12:29 PM - 12:34 PM Panel Discussion
12:35 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: VENOUS SOCIETAL AND GOVERNANCE
x
1:00 PM - 1:05 PM CMS Policy Update On Nonthermal Ablation
  Presenter(s):Harold J. Welch, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM The Future Of Venous Reimbursement In A Non-Fee For Service Environment
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
1:12 PM - 1:17 PM What Are The Next Venous Trials
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
  View Slides in PDF      
1:18 PM - 1:23 PM Diametric Opposite CMS Trends In Arterial And Venous Procedures: Implications For Manpower And Training
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Is The Vein Center Accreditation Important For MACRA
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Update On Deep Venous Accreditation
  Presenter(s):Stephen F. Daugherty, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Appropriateness In Venous Surgery - What's The Problem
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM How Can Appropriate Use Criteria Help Curb Inappropriate Venous Care
  Presenter(s):Elna M. Masuda, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Results Of Appropriateness Criteria (AVF) II
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Can VQI Be Used As A Benchmark For Setting Ethical Standards